date generated: 2022-10-13
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik -0.23492611
## 0610009E02Rik -0.09139988
## 0610009L18Rik -1.43010001
## 0610010K14Rik -0.78295210
## 0610012G03Rik -0.10566247
## 0610030E20Rik -0.39636314
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 17319 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8454 |
num_profile_genes_not_in_sets | 8865 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Gene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 423 |
num_genesets_included | 1181 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
EUKARYOTIC TRANSLATION ELONGATION | 88 | 5.90e-27 | -0.662 | 3.48e-24 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 96 | 1.03e-27 | -0.644 | 1.21e-24 |
SCAVENGING OF HEME FROM PLASMA | 12 | 2.04e-04 | 0.619 | 4.38e-03 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 107 | 1.56e-26 | -0.596 | 6.15e-24 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 3.33e-04 | 0.575 | 6.66e-03 |
ATTENUATION PHASE | 25 | 1.25e-06 | -0.560 | 4.63e-05 |
NONSENSE MEDIATED DECAY NMD | 110 | 4.85e-24 | -0.558 | 1.15e-21 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 1.58e-03 | 0.550 | 2.19e-02 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 4.37e-04 | 0.524 | 8.20e-03 |
SELENOAMINO ACID METABOLISM | 110 | 1.46e-20 | -0.513 | 2.46e-18 |
EUKARYOTIC TRANSLATION INITIATION | 115 | 1.57e-19 | -0.488 | 2.06e-17 |
SEROTONIN RECEPTORS | 10 | 8.62e-03 | 0.480 | 7.14e-02 |
ASPARTATE AND ASPARAGINE METABOLISM | 11 | 6.19e-03 | 0.477 | 5.75e-02 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 13 | 3.16e-03 | -0.473 | 3.52e-02 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 4.10e-03 | 0.460 | 4.29e-02 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 1.07e-02 | 0.444 | 7.86e-02 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 165 | 1.14e-22 | -0.442 | 2.25e-20 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 4.80e-04 | 0.440 | 8.73e-03 |
FGFR2 ALTERNATIVE SPLICING | 25 | 1.65e-04 | -0.435 | 3.67e-03 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 2.60e-03 | 0.435 | 3.08e-02 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 1.32e-02 | 0.432 | 8.85e-02 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 9.65e-03 | 0.431 | 7.60e-02 |
RHOBTB2 GTPASE CYCLE | 23 | 3.81e-04 | -0.428 | 7.38e-03 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 4.57e-03 | -0.423 | 4.62e-02 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 7.19e-04 | 0.417 | 1.16e-02 |
INFLUENZA INFECTION | 146 | 1.05e-17 | -0.411 | 1.24e-15 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 2.54e-02 | -0.408 | 1.34e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 21 | 1.21e-03 | 0.408 | 1.79e-02 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 2.59e-02 | 0.407 | 1.34e-01 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 1.15e-02 | 0.405 | 8.14e-02 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 1.04e-07 | -0.400 | 5.36e-06 |
HSF1 ACTIVATION | 27 | 3.54e-04 | -0.397 | 6.96e-03 |
GLYCOSPHINGOLIPID METABOLISM | 37 | 3.18e-05 | 0.395 | 8.16e-04 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 8.15e-03 | 0.395 | 6.87e-02 |
COMPLEX I BIOGENESIS | 56 | 4.45e-07 | -0.390 | 1.94e-05 |
RHOBTB3 ATPASE CYCLE | 10 | 3.37e-02 | 0.388 | 1.49e-01 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 13 | 1.57e-02 | 0.387 | 9.89e-02 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 7.51e-03 | 0.386 | 6.52e-02 |
G PROTEIN ACTIVATION | 23 | 1.39e-03 | -0.385 | 2.02e-02 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 3.51e-02 | 0.385 | 1.53e-01 |
FCGR ACTIVATION | 11 | 2.84e-02 | 0.382 | 1.37e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 1.37e-07 | -0.378 | 6.72e-06 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 1.88e-02 | 0.376 | 1.08e-01 |
RRNA PROCESSING | 195 | 1.40e-19 | -0.376 | 2.06e-17 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 1.36e-02 | 0.368 | 8.92e-02 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 14 | 1.86e-02 | -0.363 | 1.08e-01 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 18 | 7.81e-03 | -0.362 | 6.63e-02 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 4.96e-02 | 0.359 | 1.84e-01 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 4.15e-02 | -0.355 | 1.66e-01 |
DISEASES OF DNA REPAIR | 11 | 4.31e-02 | -0.352 | 1.70e-01 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
EUKARYOTIC TRANSLATION ELONGATION | 88 | 5.90e-27 | -0.662000 | 3.48e-24 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 96 | 1.03e-27 | -0.644000 | 1.21e-24 |
SCAVENGING OF HEME FROM PLASMA | 12 | 2.04e-04 | 0.619000 | 4.38e-03 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 107 | 1.56e-26 | -0.596000 | 6.15e-24 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 3.33e-04 | 0.575000 | 6.66e-03 |
ATTENUATION PHASE | 25 | 1.25e-06 | -0.560000 | 4.63e-05 |
NONSENSE MEDIATED DECAY NMD | 110 | 4.85e-24 | -0.558000 | 1.15e-21 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 1.58e-03 | 0.550000 | 2.19e-02 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 4.37e-04 | 0.524000 | 8.20e-03 |
SELENOAMINO ACID METABOLISM | 110 | 1.46e-20 | -0.513000 | 2.46e-18 |
EUKARYOTIC TRANSLATION INITIATION | 115 | 1.57e-19 | -0.488000 | 2.06e-17 |
SEROTONIN RECEPTORS | 10 | 8.62e-03 | 0.480000 | 7.14e-02 |
ASPARTATE AND ASPARAGINE METABOLISM | 11 | 6.19e-03 | 0.477000 | 5.75e-02 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 13 | 3.16e-03 | -0.473000 | 3.52e-02 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 4.10e-03 | 0.460000 | 4.29e-02 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 1.07e-02 | 0.444000 | 7.86e-02 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 165 | 1.14e-22 | -0.442000 | 2.25e-20 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 4.80e-04 | 0.440000 | 8.73e-03 |
FGFR2 ALTERNATIVE SPLICING | 25 | 1.65e-04 | -0.435000 | 3.67e-03 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 2.60e-03 | 0.435000 | 3.08e-02 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 1.32e-02 | 0.432000 | 8.85e-02 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 9.65e-03 | 0.431000 | 7.60e-02 |
RHOBTB2 GTPASE CYCLE | 23 | 3.81e-04 | -0.428000 | 7.38e-03 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 4.57e-03 | -0.423000 | 4.62e-02 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 7.19e-04 | 0.417000 | 1.16e-02 |
INFLUENZA INFECTION | 146 | 1.05e-17 | -0.411000 | 1.24e-15 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 2.54e-02 | -0.408000 | 1.34e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 21 | 1.21e-03 | 0.408000 | 1.79e-02 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 2.59e-02 | 0.407000 | 1.34e-01 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 1.15e-02 | 0.405000 | 8.14e-02 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 1.04e-07 | -0.400000 | 5.36e-06 |
HSF1 ACTIVATION | 27 | 3.54e-04 | -0.397000 | 6.96e-03 |
GLYCOSPHINGOLIPID METABOLISM | 37 | 3.18e-05 | 0.395000 | 8.16e-04 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 8.15e-03 | 0.395000 | 6.87e-02 |
COMPLEX I BIOGENESIS | 56 | 4.45e-07 | -0.390000 | 1.94e-05 |
RHOBTB3 ATPASE CYCLE | 10 | 3.37e-02 | 0.388000 | 1.49e-01 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 13 | 1.57e-02 | 0.387000 | 9.89e-02 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 7.51e-03 | 0.386000 | 6.52e-02 |
G PROTEIN ACTIVATION | 23 | 1.39e-03 | -0.385000 | 2.02e-02 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 3.51e-02 | 0.385000 | 1.53e-01 |
FCGR ACTIVATION | 11 | 2.84e-02 | 0.382000 | 1.37e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 1.37e-07 | -0.378000 | 6.72e-06 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 1.88e-02 | 0.376000 | 1.08e-01 |
RRNA PROCESSING | 195 | 1.40e-19 | -0.376000 | 2.06e-17 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 1.36e-02 | 0.368000 | 8.92e-02 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 14 | 1.86e-02 | -0.363000 | 1.08e-01 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 18 | 7.81e-03 | -0.362000 | 6.63e-02 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 4.96e-02 | 0.359000 | 1.84e-01 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 4.15e-02 | -0.355000 | 1.66e-01 |
DISEASES OF DNA REPAIR | 11 | 4.31e-02 | -0.352000 | 1.70e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 3.01e-02 | -0.347000 | 1.41e-01 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 4.85e-02 | 0.344000 | 1.81e-01 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 4.04e-02 | 0.342000 | 1.65e-01 |
MRNA SPLICING MINOR PATHWAY | 52 | 2.09e-05 | -0.341000 | 6.32e-04 |
CELLULAR RESPONSE TO STARVATION | 147 | 1.02e-12 | -0.341000 | 8.60e-11 |
SCAVENGING BY CLASS A RECEPTORS | 14 | 2.83e-02 | -0.339000 | 1.37e-01 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 13 | 3.49e-02 | -0.338000 | 1.53e-01 |
SIGNALING BY ROBO RECEPTORS | 210 | 4.02e-17 | -0.337000 | 4.32e-15 |
PROLONGED ERK ACTIVATION EVENTS | 14 | 2.92e-02 | 0.337000 | 1.38e-01 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 3.61e-02 | -0.336000 | 1.55e-01 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 3.09e-03 | -0.335000 | 3.48e-02 |
ERKS ARE INACTIVATED | 13 | 3.73e-02 | 0.334000 | 1.57e-01 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 5.61e-02 | 0.333000 | 1.94e-01 |
NR1H2 NR1H3 REGULATE GENE EXPRESSION LINKED TO LIPOGENESIS | 10 | 6.90e-02 | 0.332000 | 2.23e-01 |
MATURATION OF NUCLEOPROTEIN | 10 | 6.97e-02 | -0.331000 | 2.24e-01 |
OLFACTORY SIGNALING PATHWAY | 30 | 1.71e-03 | -0.331000 | 2.32e-02 |
VITAMIN B5 PANTOTHENATE METABOLISM | 15 | 2.71e-02 | 0.330000 | 1.36e-01 |
REVERSIBLE HYDRATION OF CARBON DIOXIDE | 10 | 7.29e-02 | 0.327000 | 2.30e-01 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 36 | 7.05e-04 | -0.326000 | 1.16e-02 |
ERK MAPK TARGETS | 22 | 8.65e-03 | 0.323000 | 7.14e-02 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 5.87e-05 | 0.322000 | 1.45e-03 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 4.44e-02 | -0.322000 | 1.72e-01 |
HSF1 DEPENDENT TRANSACTIVATION | 35 | 1.02e-03 | -0.321000 | 1.57e-02 |
MRNA SPLICING | 188 | 4.05e-14 | -0.320000 | 3.68e-12 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 25 | 5.66e-03 | 0.320000 | 5.44e-02 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 6.71e-02 | 0.319000 | 2.19e-01 |
SIGNALING BY WNT IN CANCER | 31 | 2.14e-03 | 0.319000 | 2.69e-02 |
TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 10 | 8.15e-02 | -0.318000 | 2.50e-01 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 1.45e-02 | 0.316000 | 9.28e-02 |
SIGNALING BY EGFR IN CANCER | 22 | 1.05e-02 | -0.315000 | 7.84e-02 |
SYNTHESIS OF PC | 27 | 4.66e-03 | 0.315000 | 4.66e-02 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 6.20e-02 | 0.311000 | 2.07e-01 |
UNWINDING OF DNA | 12 | 6.20e-02 | 0.311000 | 2.07e-01 |
DAG AND IP3 SIGNALING | 40 | 6.68e-04 | 0.311000 | 1.13e-02 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 29 | 3.81e-03 | 0.310000 | 4.05e-02 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 5.31e-03 | 0.310000 | 5.24e-02 |
NRAGE SIGNALS DEATH THROUGH JNK | 56 | 6.06e-05 | 0.310000 | 1.46e-03 |
INOSITOL PHOSPHATE METABOLISM | 46 | 2.77e-04 | 0.310000 | 5.75e-03 |
HEME BIOSYNTHESIS | 13 | 5.72e-02 | 0.305000 | 1.97e-01 |
INTRA GOLGI TRAFFIC | 43 | 5.75e-04 | 0.304000 | 1.03e-02 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 9.76e-02 | 0.303000 | 2.81e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 2.66e-02 | 0.302000 | 1.36e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 24 | 1.05e-02 | -0.302000 | 7.84e-02 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 5.10e-02 | 0.301000 | 1.88e-01 |
INTERFERON ALPHA BETA SIGNALING | 57 | 8.57e-05 | -0.301000 | 2.02e-03 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 14 | 5.15e-02 | 0.301000 | 1.88e-01 |
PLATELET CALCIUM HOMEOSTASIS | 25 | 9.47e-03 | 0.300000 | 7.56e-02 |
HDMS DEMETHYLATE HISTONES | 26 | 8.74e-03 | 0.297000 | 7.17e-02 |
RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 5.56e-02 | 0.296000 | 1.94e-01 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 1.09e-01 | 0.292000 | 3.03e-01 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 2.45e-02 | 0.291000 | 1.33e-01 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 2.89e-02 | -0.290000 | 1.38e-01 |
NICOTINAMIDE SALVAGING | 15 | 5.27e-02 | -0.289000 | 1.90e-01 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 13 | 7.19e-02 | 0.288000 | 2.28e-01 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 29 | 7.47e-03 | 0.287000 | 6.52e-02 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 6.21e-07 | -0.286000 | 2.53e-05 |
SPHINGOLIPID METABOLISM | 78 | 1.29e-05 | 0.286000 | 4.02e-04 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 34 | 3.97e-03 | -0.286000 | 4.18e-02 |
TRANSLATION | 287 | 9.18e-17 | -0.285000 | 9.03e-15 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 1.18e-02 | -0.285000 | 8.29e-02 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 2.37e-02 | 0.285000 | 1.29e-01 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 1.19e-01 | 0.284000 | 3.21e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 16 | 4.94e-02 | 0.284000 | 1.84e-01 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 17 | 4.37e-02 | -0.283000 | 1.71e-01 |
DARPP 32 EVENTS | 23 | 1.94e-02 | 0.282000 | 1.11e-01 |
CA DEPENDENT EVENTS | 36 | 3.58e-03 | 0.281000 | 3.88e-02 |
TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 12 | 9.33e-02 | 0.280000 | 2.72e-01 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 87 | 6.58e-06 | 0.280000 | 2.22e-04 |
CD28 DEPENDENT PI3K AKT SIGNALING | 21 | 2.70e-02 | 0.279000 | 1.36e-01 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 2.73e-02 | 0.278000 | 1.36e-01 |
VXPX CARGO TARGETING TO CILIUM | 19 | 3.59e-02 | 0.278000 | 1.55e-01 |
PRE NOTCH PROCESSING IN GOLGI | 17 | 4.73e-02 | 0.278000 | 1.78e-01 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 9.63e-02 | 0.277000 | 2.79e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 5.53e-02 | 0.277000 | 1.94e-01 |
DNA METHYLATION | 19 | 3.75e-02 | -0.276000 | 1.57e-01 |
VOLTAGE GATED POTASSIUM CHANNELS | 39 | 3.00e-03 | 0.275000 | 3.48e-02 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 20 | 3.36e-02 | 0.275000 | 1.49e-01 |
P75NTR REGULATES AXONOGENESIS | 10 | 1.34e-01 | 0.274000 | 3.48e-01 |
PI METABOLISM | 80 | 2.38e-05 | 0.273000 | 6.72e-04 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 10 | 1.35e-01 | 0.273000 | 3.48e-01 |
MYOGENESIS | 24 | 2.14e-02 | 0.271000 | 1.20e-01 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 23 | 2.49e-02 | -0.270000 | 1.33e-01 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 9.18e-04 | 0.268000 | 1.45e-02 |
SIGNALING BY FGFR2 IIIA TM | 19 | 4.38e-02 | -0.267000 | 1.71e-01 |
GLUCONEOGENESIS | 27 | 1.64e-02 | 0.267000 | 1.01e-01 |
GLUCAGON TYPE LIGAND RECEPTORS | 26 | 1.86e-02 | -0.267000 | 1.08e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 1.46e-01 | 0.265000 | 3.64e-01 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 4.74e-02 | 0.263000 | 1.78e-01 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 1.32e-01 | 0.262000 | 3.43e-01 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 1.33e-01 | -0.261000 | 3.46e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 5.35e-12 | -0.260000 | 3.71e-10 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 3.08e-02 | -0.260000 | 1.43e-01 |
ION TRANSPORT BY P TYPE ATPASES | 48 | 1.88e-03 | 0.259000 | 2.41e-02 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 4.48e-02 | 0.259000 | 1.72e-01 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 4.00e-02 | 0.259000 | 1.64e-01 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 5.86e-07 | -0.259000 | 2.47e-05 |
INTERLEUKIN 6 FAMILY SIGNALING | 19 | 5.16e-02 | 0.258000 | 1.88e-01 |
IRAK4 DEFICIENCY TLR2 4 | 13 | 1.08e-01 | 0.258000 | 2.99e-01 |
PRC2 METHYLATES HISTONES AND DNA | 28 | 1.85e-02 | -0.257000 | 1.08e-01 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 2.10e-02 | 0.257000 | 1.19e-01 |
LONG TERM POTENTIATION | 23 | 3.35e-02 | 0.256000 | 1.49e-01 |
EARLY PHASE OF HIV LIFE CYCLE | 13 | 1.10e-01 | -0.256000 | 3.04e-01 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 1.26e-02 | 0.255000 | 8.64e-02 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 2.48e-02 | 0.254000 | 1.33e-01 |
SHC MEDIATED CASCADE FGFR3 | 12 | 1.27e-01 | 0.254000 | 3.37e-01 |
RAP1 SIGNALLING | 15 | 8.87e-02 | 0.254000 | 2.63e-01 |
MITOCHONDRIAL TRANSLATION | 93 | 2.39e-05 | -0.254000 | 6.72e-04 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 6.26e-02 | -0.254000 | 2.08e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 27 | 2.32e-02 | 0.253000 | 1.27e-01 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 1.37e-02 | -0.252000 | 8.96e-02 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 1.03e-01 | 0.251000 | 2.93e-01 |
G PROTEIN MEDIATED EVENTS | 52 | 1.81e-03 | 0.250000 | 2.40e-02 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 1.08e-01 | -0.248000 | 2.99e-01 |
TIGHT JUNCTION INTERACTIONS | 18 | 6.84e-02 | 0.248000 | 2.22e-01 |
STRIATED MUSCLE CONTRACTION | 26 | 2.86e-02 | -0.248000 | 1.37e-01 |
KERATAN SULFATE BIOSYNTHESIS | 26 | 2.95e-02 | 0.247000 | 1.39e-01 |
MTOR SIGNALLING | 41 | 6.35e-03 | 0.246000 | 5.86e-02 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 6.33e-02 | -0.246000 | 2.09e-01 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 54 | 1.80e-03 | -0.246000 | 2.40e-02 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 21 | 5.16e-02 | -0.245000 | 1.88e-01 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 4.17e-02 | -0.245000 | 1.66e-01 |
SIALIC ACID METABOLISM | 32 | 1.64e-02 | 0.245000 | 1.01e-01 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 24 | 3.84e-02 | 0.244000 | 1.60e-01 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 1.69e-02 | 0.244000 | 1.03e-01 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 2.60e-02 | 0.243000 | 1.34e-01 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 26 | 3.20e-02 | 0.243000 | 1.47e-01 |
PARASITE INFECTION | 57 | 1.53e-03 | 0.243000 | 2.17e-02 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 21 | 5.52e-02 | -0.242000 | 1.94e-01 |
RAF ACTIVATION | 34 | 1.51e-02 | 0.241000 | 9.53e-02 |
MICRORNA MIRNA BIOGENESIS | 24 | 4.11e-02 | -0.241000 | 1.66e-01 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 6.97e-02 | -0.240000 | 2.24e-01 |
AMINE LIGAND BINDING RECEPTORS | 29 | 2.57e-02 | 0.239000 | 1.34e-01 |
FCGR3A MEDIATED IL10 SYNTHESIS | 35 | 1.44e-02 | 0.239000 | 9.28e-02 |
BASE EXCISION REPAIR AP SITE FORMATION | 28 | 2.87e-02 | -0.239000 | 1.37e-01 |
RHOBTB GTPASE CYCLE | 35 | 1.46e-02 | -0.239000 | 9.34e-02 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 8.12e-02 | 0.237000 | 2.50e-01 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 1.94e-01 | -0.237000 | 4.23e-01 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 1.39e-01 | 0.237000 | 3.54e-01 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 7.52e-02 | 0.236000 | 2.34e-01 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 83 | 2.14e-04 | -0.235000 | 4.50e-03 |
SIGNALING BY LEPTIN | 10 | 1.98e-01 | 0.235000 | 4.29e-01 |
METABOLISM OF RNA | 647 | 2.78e-24 | -0.235000 | 8.22e-22 |
P75NTR SIGNALS VIA NF KB | 16 | 1.04e-01 | -0.235000 | 2.93e-01 |
METABOLISM OF AMINE DERIVED HORMONES | 10 | 2.00e-01 | -0.234000 | 4.30e-01 |
SHC MEDIATED CASCADE FGFR4 | 10 | 2.03e-01 | 0.232000 | 4.34e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 4.17e-03 | 0.232000 | 4.31e-02 |
FCERI MEDIATED CA 2 MOBILIZATION | 27 | 3.75e-02 | 0.231000 | 1.57e-01 |
ION CHANNEL TRANSPORT | 143 | 1.84e-06 | 0.231000 | 6.59e-05 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 2.07e-01 | -0.231000 | 4.37e-01 |
ACTIVATION OF SMO | 16 | 1.12e-01 | 0.230000 | 3.08e-01 |
O LINKED GLYCOSYLATION OF MUCINS | 41 | 1.12e-02 | 0.229000 | 7.99e-02 |
GLUCOSE METABOLISM | 79 | 4.49e-04 | 0.228000 | 8.29e-03 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 4.39e-02 | 0.228000 | 1.71e-01 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 2.84e-02 | -0.228000 | 1.37e-01 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 2.85e-02 | 0.227000 | 1.37e-01 |
CHAPERONE MEDIATED AUTOPHAGY | 20 | 7.88e-02 | -0.227000 | 2.44e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 13 | 1.60e-01 | 0.225000 | 3.79e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 20 | 8.16e-02 | -0.225000 | 2.50e-01 |
SULFUR AMINO ACID METABOLISM | 25 | 5.17e-02 | 0.225000 | 1.88e-01 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 8.18e-02 | 0.225000 | 2.50e-01 |
FRS MEDIATED FGFR3 SIGNALING | 14 | 1.47e-01 | 0.224000 | 3.64e-01 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 5.76e-02 | 0.224000 | 1.97e-01 |
CELLULAR HEXOSE TRANSPORT | 11 | 1.98e-01 | 0.224000 | 4.29e-01 |
COPII MEDIATED VESICLE TRANSPORT | 65 | 1.85e-03 | 0.223000 | 2.40e-02 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 3.07e-03 | -0.223000 | 3.48e-02 |
GAB1 SIGNALOSOME | 14 | 1.49e-01 | -0.223000 | 3.64e-01 |
STIMULI SENSING CHANNELS | 78 | 6.87e-04 | 0.222000 | 1.14e-02 |
INTERLEUKIN 6 SIGNALING | 10 | 2.24e-01 | 0.222000 | 4.58e-01 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 1.83e-01 | 0.222000 | 4.06e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 16 | 1.24e-01 | 0.222000 | 3.31e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.84e-01 | -0.221000 | 4.09e-01 |
HS GAG BIOSYNTHESIS | 30 | 3.63e-02 | 0.221000 | 1.55e-01 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 19 | 9.65e-02 | -0.220000 | 2.79e-01 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 2.29e-01 | 0.220000 | 4.64e-01 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 3.42e-02 | 0.220000 | 1.51e-01 |
PHOSPHOLIPID METABOLISM | 187 | 2.28e-07 | 0.220000 | 1.08e-05 |
RNA POLYMERASE I PROMOTER ESCAPE | 46 | 1.01e-02 | -0.219000 | 7.78e-02 |
RHO GTPASES ACTIVATE CIT | 18 | 1.08e-01 | -0.219000 | 2.99e-01 |
TBC RABGAPS | 42 | 1.42e-02 | 0.219000 | 9.25e-02 |
SIGNALLING TO ERKS | 34 | 2.86e-02 | 0.217000 | 1.37e-01 |
INSULIN RECEPTOR RECYCLING | 20 | 9.32e-02 | 0.217000 | 2.72e-01 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 2.35e-01 | 0.217000 | 4.70e-01 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 21 | 8.75e-02 | 0.215000 | 2.63e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 49 | 9.32e-03 | 0.215000 | 7.54e-02 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 7.47e-02 | -0.215000 | 2.34e-01 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 46 | 1.21e-02 | -0.214000 | 8.43e-02 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 1.82e-01 | -0.214000 | 4.06e-01 |
SIGNALING BY NOTCH3 | 48 | 1.06e-02 | -0.213000 | 7.84e-02 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 16 | 1.41e-01 | 0.213000 | 3.55e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 1.68e-01 | 0.213000 | 3.90e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 15 | 1.54e-01 | 0.213000 | 3.70e-01 |
MTORC1 MEDIATED SIGNALLING | 24 | 7.15e-02 | 0.213000 | 2.27e-01 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 6.07e-02 | 0.213000 | 2.05e-01 |
G1 S SPECIFIC TRANSCRIPTION | 27 | 5.64e-02 | 0.212000 | 1.95e-01 |
SIGNAL AMPLIFICATION | 31 | 4.19e-02 | -0.211000 | 1.67e-01 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 89 | 5.98e-04 | 0.211000 | 1.04e-02 |
CRISTAE FORMATION | 31 | 4.36e-02 | -0.209000 | 1.71e-01 |
CARGO CONCENTRATION IN THE ER | 30 | 4.72e-02 | 0.209000 | 1.78e-01 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 1.36e-01 | -0.209000 | 3.48e-01 |
SHC MEDIATED CASCADE FGFR1 | 15 | 1.61e-01 | 0.209000 | 3.80e-01 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 5.20e-02 | 0.209000 | 1.88e-01 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 6.15e-04 | 0.208000 | 1.05e-02 |
ION HOMEOSTASIS | 48 | 1.28e-02 | 0.208000 | 8.71e-02 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 23 | 8.48e-02 | 0.208000 | 2.56e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 5.98e-02 | -0.206000 | 2.03e-01 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 27 | 6.57e-02 | 0.205000 | 2.16e-01 |
APOPTOTIC EXECUTION PHASE | 45 | 1.76e-02 | 0.205000 | 1.05e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 141 | 2.94e-05 | 0.204000 | 7.71e-04 |
RAB REGULATION OF TRAFFICKING | 119 | 1.23e-04 | 0.204000 | 2.79e-03 |
HDACS DEACETYLATE HISTONES | 45 | 1.84e-02 | -0.203000 | 1.08e-01 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 26 | 7.30e-02 | -0.203000 | 2.30e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 61 | 6.09e-03 | -0.203000 | 5.71e-02 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 34 | 4.06e-02 | 0.203000 | 1.65e-01 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 198 | 9.20e-07 | 0.202000 | 3.62e-05 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 12 | 2.25e-01 | 0.202000 | 4.58e-01 |
RHOB GTPASE CYCLE | 69 | 3.68e-03 | 0.202000 | 3.95e-02 |
MUCOPOLYSACCHARIDOSES | 11 | 2.46e-01 | 0.202000 | 4.85e-01 |
KERATAN SULFATE KERATIN METABOLISM | 32 | 4.80e-02 | 0.202000 | 1.80e-01 |
FRS MEDIATED FGFR4 SIGNALING | 12 | 2.28e-01 | 0.201000 | 4.63e-01 |
G ALPHA 12 13 SIGNALLING EVENTS | 76 | 2.50e-03 | 0.201000 | 2.98e-02 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 74 | 3.04e-03 | 0.199000 | 3.48e-02 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 85 | 1.55e-03 | 0.199000 | 2.17e-02 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 1.09e-02 | 0.199000 | 7.86e-02 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 171 | 7.64e-06 | 0.199000 | 2.51e-04 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 1.59e-01 | 0.198000 | 3.77e-01 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 14 | 2.02e-01 | 0.197000 | 4.32e-01 |
HEDGEHOG LIGAND BIOGENESIS | 62 | 7.29e-03 | -0.197000 | 6.47e-02 |
SIGNALING BY NODAL | 16 | 1.74e-01 | 0.196000 | 3.96e-01 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 1.88e-01 | -0.196000 | 4.16e-01 |
CTLA4 INHIBITORY SIGNALING | 20 | 1.29e-01 | 0.196000 | 3.40e-01 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 2.05e-01 | 0.196000 | 4.35e-01 |
ONCOGENE INDUCED SENESCENCE | 32 | 5.56e-02 | -0.196000 | 1.94e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 84 | 1.97e-03 | 0.195000 | 2.50e-02 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 64 | 6.88e-03 | -0.195000 | 6.20e-02 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 24 | 9.87e-02 | -0.195000 | 2.83e-01 |
NCAM1 INTERACTIONS | 41 | 3.13e-02 | -0.194000 | 1.45e-01 |
PLATELET AGGREGATION PLUG FORMATION | 31 | 6.29e-02 | 0.193000 | 2.09e-01 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 2.08e-02 | 0.193000 | 1.18e-01 |
STABILIZATION OF P53 | 55 | 1.34e-02 | -0.193000 | 8.91e-02 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 2.51e-01 | -0.191000 | 4.91e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 65 | 7.68e-03 | -0.191000 | 6.58e-02 |
RECYCLING PATHWAY OF L1 | 40 | 3.65e-02 | 0.191000 | 1.56e-01 |
CARNITINE METABOLISM | 14 | 2.16e-01 | 0.191000 | 4.49e-01 |
INTERLEUKIN 20 FAMILY SIGNALING | 14 | 2.16e-01 | 0.191000 | 4.49e-01 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 13 | 2.35e-01 | -0.190000 | 4.70e-01 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 2.90e-02 | 0.190000 | 1.38e-01 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 2.35e-01 | -0.190000 | 4.70e-01 |
PEROXISOMAL LIPID METABOLISM | 27 | 8.79e-02 | 0.190000 | 2.63e-01 |
FRS MEDIATED FGFR1 SIGNALING | 17 | 1.76e-01 | 0.190000 | 3.98e-01 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 2.99e-01 | 0.190000 | 5.44e-01 |
ZINC TRANSPORTERS | 16 | 1.90e-01 | 0.189000 | 4.19e-01 |
DISEASES OF IMMUNE SYSTEM | 25 | 1.04e-01 | 0.188000 | 2.93e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 1.57e-01 | -0.188000 | 3.75e-01 |
RHOG GTPASE CYCLE | 74 | 5.37e-03 | 0.187000 | 5.25e-02 |
G0 AND EARLY G1 | 26 | 9.90e-02 | 0.187000 | 2.83e-01 |
BILE ACID AND BILE SALT METABOLISM | 27 | 9.39e-02 | 0.186000 | 2.73e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 3.98e-02 | 0.186000 | 1.64e-01 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 6.20e-02 | 0.185000 | 2.07e-01 |
NUCLEOBASE CATABOLISM | 31 | 7.52e-02 | 0.185000 | 2.34e-01 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 15 | 2.16e-01 | -0.184000 | 4.49e-01 |
METABOLISM OF CARBOHYDRATES | 260 | 3.20e-07 | 0.184000 | 1.45e-05 |
GENERATION OF SECOND MESSENGER MOLECULES | 19 | 1.68e-01 | -0.183000 | 3.90e-01 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 29 | 8.88e-02 | -0.183000 | 2.63e-01 |
COLLAGEN CHAIN TRIMERIZATION | 42 | 4.06e-02 | -0.183000 | 1.65e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 1.71e-02 | -0.183000 | 1.03e-01 |
SIGNALING BY FGFR2 IN DISEASE | 36 | 5.82e-02 | -0.182000 | 1.98e-01 |
RAC1 GTPASE CYCLE | 179 | 2.62e-05 | 0.182000 | 7.21e-04 |
PYRUVATE METABOLISM | 27 | 1.01e-01 | 0.182000 | 2.89e-01 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 52 | 2.31e-02 | 0.182000 | 1.27e-01 |
JOSEPHIN DOMAIN DUBS | 11 | 2.96e-01 | -0.182000 | 5.43e-01 |
INTERLEUKIN 17 SIGNALING | 67 | 1.01e-02 | 0.182000 | 7.78e-02 |
SIGNALING BY INSULIN RECEPTOR | 62 | 1.36e-02 | 0.181000 | 8.92e-02 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 31 | 8.08e-02 | -0.181000 | 2.49e-01 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 30 | 8.60e-02 | -0.181000 | 2.59e-01 |
TELOMERE MAINTENANCE | 77 | 6.07e-03 | -0.181000 | 5.71e-02 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 102 | 1.62e-03 | -0.181000 | 2.22e-02 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 2.26e-01 | -0.181000 | 4.60e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 3.63e-02 | -0.180000 | 1.55e-01 |
INTERFERON GAMMA SIGNALING | 80 | 5.33e-03 | -0.180000 | 5.24e-02 |
PROTEIN METHYLATION | 17 | 1.98e-01 | -0.180000 | 4.29e-01 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 1.68e-02 | -0.180000 | 1.03e-01 |
NEURONAL SYSTEM | 373 | 2.58e-09 | 0.180000 | 1.53e-07 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 1.99e-01 | 0.180000 | 4.30e-01 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 12 | 2.82e-01 | 0.179000 | 5.29e-01 |
HIV TRANSCRIPTION ELONGATION | 42 | 4.45e-02 | -0.179000 | 1.72e-01 |
SYNTHESIS OF PE | 13 | 2.64e-01 | 0.179000 | 5.09e-01 |
POTASSIUM CHANNELS | 91 | 3.20e-03 | 0.179000 | 3.53e-02 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 3.05e-01 | 0.179000 | 5.51e-01 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 3.28e-01 | -0.179000 | 5.77e-01 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 3.28e-01 | 0.179000 | 5.77e-01 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 2.48e-01 | 0.178000 | 4.87e-01 |
INTEGRIN SIGNALING | 24 | 1.32e-01 | 0.178000 | 3.43e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 1.60e-01 | -0.177000 | 3.79e-01 |
CHONDROITIN SULFATE BIOSYNTHESIS | 18 | 1.93e-01 | 0.177000 | 4.22e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 114 | 1.13e-03 | -0.177000 | 1.69e-02 |
RAC2 GTPASE CYCLE | 88 | 4.25e-03 | 0.176000 | 4.36e-02 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 2.38e-01 | 0.176000 | 4.73e-01 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 45 | 4.22e-02 | -0.175000 | 1.67e-01 |
KERATAN SULFATE DEGRADATION | 12 | 2.95e-01 | 0.175000 | 5.43e-01 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 47 | 3.86e-02 | -0.174000 | 1.60e-01 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 50 | 3.35e-02 | -0.174000 | 1.49e-01 |
PREGNENOLONE BIOSYNTHESIS | 12 | 2.97e-01 | -0.174000 | 5.43e-01 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 108 | 1.83e-03 | 0.174000 | 2.40e-02 |
PI 3K CASCADE FGFR3 | 12 | 2.98e-01 | 0.174000 | 5.43e-01 |
SIGNALING BY VEGF | 103 | 2.41e-03 | 0.173000 | 2.90e-02 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 23 | 1.51e-01 | -0.173000 | 3.64e-01 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 70 | 1.25e-02 | -0.173000 | 8.60e-02 |
NONHOMOLOGOUS END JOINING NHEJ | 42 | 5.35e-02 | -0.172000 | 1.91e-01 |
DEGRADATION OF DVL | 56 | 2.60e-02 | -0.172000 | 1.34e-01 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 186 | 5.29e-05 | 0.172000 | 1.33e-03 |
NUCLEAR ENVELOPE BREAKDOWN | 49 | 3.75e-02 | 0.172000 | 1.57e-01 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 7.09e-02 | -0.172000 | 2.26e-01 |
MEMBRANE TRAFFICKING | 581 | 2.13e-12 | 0.171000 | 1.58e-10 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 5.82e-02 | -0.171000 | 1.98e-01 |
GLYCOLYSIS | 65 | 1.72e-02 | 0.171000 | 1.03e-01 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 28 | 1.18e-01 | 0.170000 | 3.21e-01 |
PHASE 0 RAPID DEPOLARISATION | 28 | 1.19e-01 | 0.170000 | 3.21e-01 |
COLLAGEN DEGRADATION | 52 | 3.41e-02 | -0.170000 | 1.51e-01 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 2.55e-01 | -0.170000 | 4.97e-01 |
RNA POLYMERASE I TRANSCRIPTION | 66 | 1.72e-02 | -0.170000 | 1.03e-01 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 2.14e-02 | 0.169000 | 1.20e-01 |
RHOU GTPASE CYCLE | 34 | 8.88e-02 | 0.169000 | 2.63e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 20 | 1.92e-01 | 0.169000 | 4.21e-01 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 2.43e-01 | -0.169000 | 4.82e-01 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 9.44e-02 | -0.168000 | 2.74e-01 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.63e-01 | 0.168000 | 3.82e-01 |
GLYCOGEN METABOLISM | 25 | 1.48e-01 | 0.167000 | 3.64e-01 |
PYROPTOSIS | 21 | 1.85e-01 | -0.167000 | 4.09e-01 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 68 | 1.72e-02 | -0.167000 | 1.03e-01 |
VESICLE MEDIATED TRANSPORT | 615 | 1.78e-12 | 0.167000 | 1.40e-10 |
NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 6.12e-02 | 0.167000 | 2.06e-01 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 2.68e-02 | -0.167000 | 1.36e-01 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 1.03e-01 | -0.166000 | 2.93e-01 |
RHOA GTPASE CYCLE | 144 | 5.82e-04 | 0.166000 | 1.03e-02 |
VLDLR INTERNALISATION AND DEGRADATION | 11 | 3.42e-01 | 0.165000 | 5.92e-01 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 93 | 5.89e-03 | 0.165000 | 5.61e-02 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 1.12e-02 | -0.165000 | 7.99e-02 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 92 | 6.45e-03 | 0.164000 | 5.90e-02 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 3.25e-01 | 0.164000 | 5.72e-01 |
HEME SIGNALING | 45 | 5.77e-02 | 0.164000 | 1.97e-01 |
RORA ACTIVATES GENE EXPRESSION | 18 | 2.30e-01 | 0.163000 | 4.66e-01 |
SYNTHESIS OF PA | 29 | 1.28e-01 | 0.163000 | 3.37e-01 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 27 | 1.42e-01 | 0.163000 | 3.58e-01 |
METABOLISM OF PORPHYRINS | 19 | 2.20e-01 | 0.163000 | 4.54e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 1.02e-01 | 0.162000 | 2.89e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 43 | 6.61e-02 | 0.162000 | 2.17e-01 |
ORGANIC CATION ANION ZWITTERION TRANSPORT | 11 | 3.53e-01 | 0.162000 | 6.00e-01 |
LYSINE CATABOLISM | 11 | 3.54e-01 | 0.161000 | 6.01e-01 |
ENDOSOMAL VACUOLAR PATHWAY | 11 | 3.55e-01 | -0.161000 | 6.01e-01 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 20 | 2.13e-01 | -0.161000 | 4.47e-01 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 1.04e-02 | 0.161000 | 7.84e-02 |
PLATELET SENSITIZATION BY LDL | 16 | 2.67e-01 | 0.160000 | 5.12e-01 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 27 | 1.49e-01 | -0.160000 | 3.64e-01 |
GLYCOSAMINOGLYCAN METABOLISM | 116 | 2.98e-03 | 0.160000 | 3.48e-02 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 2.05e-01 | 0.160000 | 4.35e-01 |
TRP CHANNELS | 20 | 2.18e-01 | 0.159000 | 4.52e-01 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 2.43e-01 | -0.159000 | 4.82e-01 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 1.19e-01 | 0.159000 | 3.21e-01 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 20 | 2.21e-01 | -0.158000 | 4.54e-01 |
ESTROGEN DEPENDENT GENE EXPRESSION | 103 | 5.67e-03 | -0.158000 | 5.44e-02 |
SIGNALING BY FLT3 FUSION PROTEINS | 19 | 2.34e-01 | 0.158000 | 4.70e-01 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 245 | 2.18e-05 | 0.158000 | 6.43e-04 |
FATTY ACID METABOLISM | 148 | 9.43e-04 | 0.158000 | 1.47e-02 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 9.43e-03 | 0.158000 | 7.56e-02 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 4.56e-02 | -0.157000 | 1.74e-01 |
INSULIN PROCESSING | 25 | 1.74e-01 | 0.157000 | 3.96e-01 |
TOLL LIKE RECEPTOR CASCADES | 138 | 1.45e-03 | 0.157000 | 2.09e-02 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 9.88e-02 | 0.157000 | 2.83e-01 |
CD28 CO STIMULATION | 31 | 1.32e-01 | 0.156000 | 3.43e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 180 | 3.04e-04 | -0.156000 | 6.19e-03 |
SIGNALING BY FGFR2 | 63 | 3.22e-02 | -0.156000 | 1.47e-01 |
GAP JUNCTION DEGRADATION | 11 | 3.70e-01 | 0.156000 | 6.15e-01 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 85 | 1.30e-02 | -0.156000 | 8.83e-02 |
INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 1.61e-01 | 0.156000 | 3.80e-01 |
GOLGI TO ER RETROGRADE TRANSPORT | 120 | 3.24e-03 | 0.156000 | 3.55e-02 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 3.51e-01 | 0.156000 | 5.98e-01 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 3.73e-01 | 0.155000 | 6.16e-01 |
NUCLEOBASE BIOSYNTHESIS | 15 | 2.98e-01 | 0.155000 | 5.43e-01 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 2.44e-01 | 0.155000 | 4.83e-01 |
DEGRADATION OF AXIN | 54 | 4.96e-02 | -0.155000 | 1.84e-01 |
CELL CELL JUNCTION ORGANIZATION | 52 | 5.55e-02 | 0.154000 | 1.94e-01 |
ENDOGENOUS STEROLS | 20 | 2.35e-01 | -0.153000 | 4.70e-01 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 2.24e-01 | 0.153000 | 4.58e-01 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 31 | 1.40e-01 | -0.153000 | 3.55e-01 |
FERTILIZATION | 11 | 3.82e-01 | -0.152000 | 6.21e-01 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 5.53e-02 | -0.152000 | 1.94e-01 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 4.05e-01 | 0.152000 | 6.41e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 28 | 1.64e-01 | -0.152000 | 3.83e-01 |
METABOLISM OF LIPIDS | 619 | 1.24e-10 | 0.152000 | 8.12e-09 |
TRANSPORT OF SMALL MOLECULES | 590 | 3.27e-10 | 0.152000 | 2.04e-08 |
CELLULAR RESPONSE TO HYPOXIA | 73 | 2.51e-02 | -0.152000 | 1.34e-01 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 1.58e-01 | -0.152000 | 3.77e-01 |
CHROMOSOME MAINTENANCE | 100 | 8.91e-03 | -0.151000 | 7.26e-02 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 95 | 1.09e-02 | 0.151000 | 7.86e-02 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 1.59e-01 | 0.151000 | 3.77e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 2.27e-02 | 0.151000 | 1.26e-01 |
REGULATION OF IFNA SIGNALING | 12 | 3.64e-01 | -0.151000 | 6.09e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 2.51e-02 | -0.151000 | 1.34e-01 |
BASE EXCISION REPAIR | 55 | 5.34e-02 | -0.151000 | 1.91e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 2.97e-01 | -0.151000 | 5.43e-01 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 16 | 2.98e-01 | 0.150000 | 5.43e-01 |
ASSEMBLY OF THE HIV VIRION | 16 | 2.99e-01 | -0.150000 | 5.43e-01 |
CGMP EFFECTS | 15 | 3.15e-01 | 0.150000 | 5.62e-01 |
AGGREPHAGY | 34 | 1.30e-01 | -0.150000 | 3.41e-01 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 29 | 1.62e-01 | 0.150000 | 3.82e-01 |
CARDIAC CONDUCTION | 107 | 7.46e-03 | 0.150000 | 6.52e-02 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 36 | 1.20e-01 | -0.150000 | 3.22e-01 |
SHC1 EVENTS IN EGFR SIGNALING | 11 | 3.91e-01 | -0.149000 | 6.30e-01 |
POLYMERASE SWITCHING | 14 | 3.34e-01 | -0.149000 | 5.85e-01 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 12 | 3.73e-01 | 0.149000 | 6.16e-01 |
MHC CLASS II ANTIGEN PRESENTATION | 102 | 9.60e-03 | 0.148000 | 7.60e-02 |
REGULATION OF SIGNALING BY CBL | 22 | 2.32e-01 | 0.147000 | 4.69e-01 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 2.81e-01 | 0.147000 | 5.26e-01 |
PURINE SALVAGE | 12 | 3.78e-01 | 0.147000 | 6.21e-01 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 25 | 2.04e-01 | 0.147000 | 4.35e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 36 | 1.28e-01 | 0.147000 | 3.37e-01 |
PURINE CATABOLISM | 16 | 3.10e-01 | 0.146000 | 5.57e-01 |
CELL JUNCTION ORGANIZATION | 77 | 2.63e-02 | 0.146000 | 1.35e-01 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 5.20e-02 | -0.146000 | 1.88e-01 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 104 | 1.01e-02 | 0.146000 | 7.78e-02 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 4.02e-01 | 0.146000 | 6.40e-01 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 59 | 5.37e-02 | -0.145000 | 1.91e-01 |
IRS MEDIATED SIGNALLING | 38 | 1.22e-01 | 0.145000 | 3.25e-01 |
PI 3K CASCADE FGFR1 | 15 | 3.33e-01 | 0.145000 | 5.84e-01 |
ASPARAGINE N LINKED GLYCOSYLATION | 285 | 2.84e-05 | 0.144000 | 7.62e-04 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 4.16e-02 | -0.144000 | 1.66e-01 |
RAS PROCESSING | 23 | 2.33e-01 | 0.144000 | 4.70e-01 |
CDC42 GTPASE CYCLE | 154 | 2.18e-03 | 0.143000 | 2.71e-02 |
MAPK6 MAPK4 SIGNALING | 85 | 2.27e-02 | -0.143000 | 1.26e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 3.73e-01 | 0.143000 | 6.16e-01 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 69 | 4.13e-02 | -0.142000 | 1.66e-01 |
TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 4.00e-02 | 0.142000 | 1.64e-01 |
SIGNALING BY RETINOIC ACID | 34 | 1.52e-01 | 0.142000 | 3.66e-01 |
RHOC GTPASE CYCLE | 74 | 3.50e-02 | 0.142000 | 1.53e-01 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 1.72e-01 | -0.142000 | 3.94e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 1.73e-01 | -0.142000 | 3.95e-01 |
RAC3 GTPASE CYCLE | 90 | 2.06e-02 | 0.141000 | 1.17e-01 |
SIGNALING BY FGFR | 73 | 3.70e-02 | -0.141000 | 1.57e-01 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 6.78e-02 | 0.141000 | 2.21e-01 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 68 | 4.42e-02 | -0.141000 | 1.72e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 74 | 3.59e-02 | -0.141000 | 1.55e-01 |
DISEASES OF GLYCOSYLATION | 124 | 6.79e-03 | 0.141000 | 6.17e-02 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 49 | 8.84e-02 | 0.141000 | 2.63e-01 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 3.17e-01 | 0.140000 | 5.65e-01 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 3.66e-01 | 0.139000 | 6.11e-01 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 2.48e-01 | -0.139000 | 4.87e-01 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 1.80e-01 | 0.139000 | 4.04e-01 |
POLO LIKE KINASE MEDIATED EVENTS | 13 | 3.86e-01 | -0.139000 | 6.25e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 4.06e-01 | 0.139000 | 6.41e-01 |
COLLAGEN FORMATION | 82 | 3.06e-02 | -0.138000 | 1.42e-01 |
NEPHRIN FAMILY INTERACTIONS | 21 | 2.73e-01 | 0.138000 | 5.16e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 4.29e-01 | -0.138000 | 6.63e-01 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 23 | 2.53e-01 | 0.138000 | 4.94e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 6.32e-02 | -0.138000 | 2.09e-01 |
O LINKED GLYCOSYLATION | 86 | 2.75e-02 | 0.138000 | 1.37e-01 |
SLC TRANSPORTER DISORDERS | 77 | 3.74e-02 | 0.137000 | 1.57e-01 |
PI3K AKT SIGNALING IN CANCER | 86 | 2.82e-02 | 0.137000 | 1.37e-01 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 58 | 7.16e-02 | -0.137000 | 2.27e-01 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 34 | 1.70e-01 | -0.136000 | 3.91e-01 |
PI 3K CASCADE FGFR4 | 10 | 4.58e-01 | 0.136000 | 6.94e-01 |
MEIOTIC RECOMBINATION | 38 | 1.49e-01 | -0.135000 | 3.64e-01 |
AMYLOID FIBER FORMATION | 56 | 8.01e-02 | -0.135000 | 2.47e-01 |
G1 S DNA DAMAGE CHECKPOINTS | 66 | 5.76e-02 | -0.135000 | 1.97e-01 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 43 | 1.25e-01 | -0.135000 | 3.33e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 93 | 2.44e-02 | 0.135000 | 1.33e-01 |
PLASMA LIPOPROTEIN REMODELING | 15 | 3.67e-01 | 0.135000 | 6.11e-01 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 1.36e-01 | 0.135000 | 3.49e-01 |
L1CAM INTERACTIONS | 107 | 1.63e-02 | 0.134000 | 1.01e-01 |
MITOTIC PROPHASE | 93 | 2.52e-02 | 0.134000 | 1.34e-01 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 36 | 1.65e-01 | 0.134000 | 3.85e-01 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 28 | 2.22e-01 | -0.133000 | 4.56e-01 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 4.24e-01 | 0.133000 | 6.59e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 288 | 1.02e-04 | 0.133000 | 2.37e-03 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 11 | 4.45e-01 | 0.133000 | 6.79e-01 |
ONCOGENIC MAPK SIGNALING | 76 | 4.49e-02 | 0.133000 | 1.72e-01 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 153 | 4.53e-03 | -0.133000 | 4.62e-02 |
MEIOTIC SYNAPSIS | 39 | 1.51e-01 | -0.133000 | 3.64e-01 |
CYTOPROTECTION BY HMOX1 | 120 | 1.20e-02 | -0.133000 | 8.37e-02 |
OPIOID SIGNALLING | 87 | 3.27e-02 | 0.133000 | 1.48e-01 |
PENTOSE PHOSPHATE PATHWAY | 13 | 4.09e-01 | -0.132000 | 6.44e-01 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 55 | 9.05e-02 | -0.132000 | 2.66e-01 |
SIGNALING BY HIPPO | 20 | 3.07e-01 | 0.132000 | 5.54e-01 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 605 | 3.31e-08 | -0.132000 | 1.78e-06 |
MRNA CAPPING | 29 | 2.19e-01 | -0.132000 | 4.53e-01 |
OXIDATIVE STRESS INDUCED SENESCENCE | 77 | 4.59e-02 | -0.132000 | 1.75e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 1.19e-01 | -0.132000 | 3.21e-01 |
METHYLATION | 11 | 4.50e-01 | 0.131000 | 6.84e-01 |
RMTS METHYLATE HISTONE ARGININES | 42 | 1.40e-01 | -0.131000 | 3.55e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 1.66e-01 | 0.131000 | 3.87e-01 |
ANTIMICROBIAL PEPTIDES | 17 | 3.48e-01 | 0.131000 | 5.95e-01 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 35 | 1.79e-01 | 0.131000 | 4.04e-01 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 3.80e-01 | -0.131000 | 6.21e-01 |
LDL CLEARANCE | 15 | 3.80e-01 | 0.131000 | 6.21e-01 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 183 | 2.31e-03 | 0.131000 | 2.82e-02 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 64 | 7.08e-02 | -0.131000 | 2.26e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 1.75e-01 | 0.131000 | 3.98e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 110 | 1.84e-02 | -0.130000 | 1.08e-01 |
CS DS DEGRADATION | 14 | 3.99e-01 | -0.130000 | 6.39e-01 |
COHESIN LOADING ONTO CHROMATIN | 10 | 4.79e-01 | 0.129000 | 7.10e-01 |
NEDDYLATION | 218 | 1.04e-03 | 0.129000 | 1.57e-02 |
GP1B IX V ACTIVATION SIGNALLING | 10 | 4.80e-01 | 0.129000 | 7.11e-01 |
ANTIGEN PROCESSING CROSS PRESENTATION | 98 | 2.79e-02 | -0.129000 | 1.37e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 1.77e-01 | 0.128000 | 4.00e-01 |
SIGNALING BY FGFR4 IN DISEASE | 10 | 4.83e-01 | -0.128000 | 7.13e-01 |
NEUREXINS AND NEUROLIGINS | 54 | 1.05e-01 | 0.128000 | 2.95e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 3.82e-01 | 0.126000 | 6.21e-01 |
REGULATED NECROSIS | 46 | 1.39e-01 | -0.126000 | 3.54e-01 |
SIGNALING BY NTRKS | 131 | 1.33e-02 | 0.125000 | 8.85e-02 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 26 | 2.69e-01 | 0.125000 | 5.14e-01 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 21 | 3.21e-01 | 0.125000 | 5.67e-01 |
RHO GTPASES ACTIVATE KTN1 | 11 | 4.74e-01 | 0.125000 | 7.03e-01 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 71 | 7.05e-02 | -0.124000 | 2.26e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 3.76e-01 | -0.124000 | 6.18e-01 |
RHO GTPASES ACTIVATE PKNS | 46 | 1.45e-01 | -0.124000 | 3.63e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 46 | 1.47e-01 | 0.124000 | 3.64e-01 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 34 | 2.13e-01 | -0.124000 | 4.47e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 3.52e-01 | -0.123000 | 6.00e-01 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 3.40e-01 | 0.123000 | 5.90e-01 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 4.42e-01 | 0.123000 | 6.76e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 132 | 1.50e-02 | 0.123000 | 9.53e-02 |
CELL CELL COMMUNICATION | 108 | 2.78e-02 | 0.123000 | 1.37e-01 |
METABOLISM OF COFACTORS | 19 | 3.57e-01 | -0.122000 | 6.03e-01 |
THE PHOTOTRANSDUCTION CASCADE | 21 | 3.33e-01 | -0.122000 | 5.84e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 2.64e-01 | 0.122000 | 5.09e-01 |
RESOLUTION OF ABASIC SITES AP SITES | 37 | 2.00e-01 | -0.122000 | 4.30e-01 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 4.66e-01 | 0.122000 | 6.99e-01 |
SIGNALING BY ERBB2 IN CANCER | 25 | 2.93e-01 | -0.122000 | 5.42e-01 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 4.86e-01 | -0.121000 | 7.14e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 1.69e-01 | 0.121000 | 3.91e-01 |
RHOF GTPASE CYCLE | 41 | 1.80e-01 | 0.121000 | 4.04e-01 |
NERVOUS SYSTEM DEVELOPMENT | 553 | 1.25e-06 | -0.121000 | 4.63e-05 |
PHASE 2 PLATEAU PHASE | 12 | 4.69e-01 | -0.121000 | 7.00e-01 |
NUCLEAR SIGNALING BY ERBB4 | 31 | 2.46e-01 | -0.120000 | 4.85e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 2.19e-01 | 0.120000 | 4.53e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 4.91e-01 | -0.120000 | 7.18e-01 |
TRIGLYCERIDE METABOLISM | 23 | 3.20e-01 | 0.120000 | 5.67e-01 |
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 5.15e-01 | 0.119000 | 7.34e-01 |
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 5.15e-01 | 0.119000 | 7.34e-01 |
TRNA AMINOACYLATION | 42 | 1.83e-01 | 0.119000 | 4.06e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 87 | 5.61e-02 | 0.119000 | 1.94e-01 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 2.70e-01 | -0.118000 | 5.14e-01 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 4.60e-01 | -0.118000 | 6.96e-01 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 7.69e-03 | -0.118000 | 6.58e-02 |
AURKA ACTIVATION BY TPX2 | 72 | 8.45e-02 | 0.118000 | 2.56e-01 |
ABC TRANSPORTER DISORDERS | 69 | 9.18e-02 | -0.117000 | 2.69e-01 |
SIGNALING BY BMP | 25 | 3.10e-01 | 0.117000 | 5.57e-01 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 30 | 2.67e-01 | 0.117000 | 5.12e-01 |
UCH PROTEINASES | 90 | 5.51e-02 | -0.117000 | 1.94e-01 |
FLT3 SIGNALING IN DISEASE | 28 | 2.85e-01 | 0.117000 | 5.32e-01 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 51 | 1.50e-01 | -0.117000 | 3.64e-01 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 21 | 3.56e-01 | 0.116000 | 6.03e-01 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 61 | 1.17e-01 | -0.116000 | 3.18e-01 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 1.64e-01 | -0.116000 | 3.83e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 4.69e-01 | -0.116000 | 7.00e-01 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 64 | 1.12e-01 | 0.115000 | 3.08e-01 |
METAL ION SLC TRANSPORTERS | 25 | 3.20e-01 | 0.115000 | 5.67e-01 |
ACYL CHAIN REMODELLING OF PE | 17 | 4.13e-01 | 0.115000 | 6.47e-01 |
SIGNALING BY NOTCH | 187 | 6.96e-03 | -0.115000 | 6.23e-02 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 120 | 3.03e-02 | 0.115000 | 1.42e-01 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 5.11e-01 | 0.115000 | 7.34e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 77 | 8.37e-02 | -0.114000 | 2.55e-01 |
INTERFERON SIGNALING | 168 | 1.09e-02 | -0.114000 | 7.86e-02 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 2.75e-01 | 0.113000 | 5.18e-01 |
TRANSLESION SYNTHESIS BY POLK | 17 | 4.19e-01 | -0.113000 | 6.56e-01 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 5.17e-01 | 0.113000 | 7.35e-01 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 11 | 5.17e-01 | 0.113000 | 7.35e-01 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 4.35e-01 | 0.113000 | 6.68e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 44 | 1.98e-01 | 0.112000 | 4.29e-01 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 12 | 5.01e-01 | 0.112000 | 7.28e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 105 | 4.72e-02 | 0.112000 | 1.78e-01 |
DEATH RECEPTOR SIGNALLING | 134 | 2.55e-02 | 0.112000 | 1.34e-01 |
G2 M CHECKPOINTS | 133 | 2.61e-02 | -0.112000 | 1.34e-01 |
SIGNALING BY NOTCH2 | 33 | 2.68e-01 | -0.111000 | 5.13e-01 |
REGULATION OF RAS BY GAPS | 67 | 1.17e-01 | -0.111000 | 3.18e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 19 | 4.03e-01 | 0.111000 | 6.40e-01 |
SIGNALLING TO RAS | 20 | 3.93e-01 | 0.110000 | 6.31e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 349 | 4.21e-04 | 0.110000 | 8.01e-03 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 3.14e-01 | -0.110000 | 5.61e-01 |
TNFR2 NON CANONICAL NF KB PATHWAY | 81 | 8.82e-02 | -0.110000 | 2.63e-01 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 4.09e-01 | 0.109000 | 6.44e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 1.43e-01 | 0.109000 | 3.60e-01 |
FCERI MEDIATED MAPK ACTIVATION | 29 | 3.08e-01 | 0.109000 | 5.55e-01 |
ADHERENS JUNCTIONS INTERACTIONS | 32 | 2.86e-01 | 0.109000 | 5.33e-01 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 58 | 1.53e-01 | 0.108000 | 3.69e-01 |
PROTEIN FOLDING | 90 | 7.67e-02 | -0.108000 | 2.38e-01 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 3.41e-01 | 0.108000 | 5.90e-01 |
HS GAG DEGRADATION | 20 | 4.03e-01 | 0.108000 | 6.40e-01 |
REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 5.54e-01 | 0.108000 | 7.61e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 71 | 1.17e-01 | 0.108000 | 3.18e-01 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 3.94e-01 | 0.107000 | 6.32e-01 |
G2 M DNA DAMAGE CHECKPOINT | 65 | 1.35e-01 | -0.107000 | 3.48e-01 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 3.19e-01 | 0.107000 | 5.67e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 51 | 1.88e-01 | -0.107000 | 4.16e-01 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 50 | 1.93e-01 | 0.106000 | 4.22e-01 |
SIGNALING BY PDGFR IN DISEASE | 20 | 4.10e-01 | 0.106000 | 6.44e-01 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 2.87e-01 | 0.106000 | 5.34e-01 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 4.65e-01 | -0.106000 | 6.99e-01 |
DISEASES OF METABOLISM | 198 | 1.08e-02 | 0.105000 | 7.86e-02 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 25 | 3.63e-01 | -0.105000 | 6.09e-01 |
REPRODUCTION | 75 | 1.16e-01 | -0.105000 | 3.17e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 2.44e-01 | 0.105000 | 4.83e-01 |
ADAPTIVE IMMUNE SYSTEM | 614 | 1.04e-05 | 0.105000 | 3.31e-04 |
FLT3 SIGNALING | 36 | 2.78e-01 | 0.105000 | 5.21e-01 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 5.50e-01 | 0.104000 | 7.61e-01 |
REGULATION OF FZD BY UBIQUITINATION | 20 | 4.24e-01 | 0.103000 | 6.59e-01 |
COMPLEMENT CASCADE | 29 | 3.37e-01 | -0.103000 | 5.88e-01 |
TRANSPORT OF ORGANIC ANIONS | 10 | 5.74e-01 | 0.103000 | 7.76e-01 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 5.55e-01 | -0.103000 | 7.61e-01 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 3.07e-01 | 0.103000 | 5.54e-01 |
RAB GERANYLGERANYLATION | 59 | 1.73e-01 | 0.103000 | 3.95e-01 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 4.92e-01 | 0.102000 | 7.19e-01 |
INFECTIOUS DISEASE | 740 | 2.45e-06 | -0.102000 | 8.51e-05 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 2.96e-01 | -0.102000 | 5.43e-01 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 5.08e-01 | -0.102000 | 7.33e-01 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 3.11e-01 | 0.102000 | 5.57e-01 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 4.82e-01 | 0.101000 | 7.12e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 94 | 8.97e-02 | -0.101000 | 2.64e-01 |
ORC1 REMOVAL FROM CHROMATIN | 68 | 1.49e-01 | -0.101000 | 3.64e-01 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 5.28e-01 | 0.101000 | 7.44e-01 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 40 | 2.70e-01 | 0.101000 | 5.14e-01 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 71 | 1.46e-01 | -0.099900 | 3.63e-01 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 3.87e-01 | -0.099900 | 6.25e-01 |
GLYCOGEN SYNTHESIS | 14 | 5.18e-01 | 0.099900 | 7.35e-01 |
INTERLEUKIN 7 SIGNALING | 18 | 4.65e-01 | 0.099600 | 6.99e-01 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 4.91e-01 | -0.099400 | 7.18e-01 |
LATE ENDOSOMAL MICROAUTOPHAGY | 31 | 3.40e-01 | -0.099100 | 5.90e-01 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 193 | 1.81e-02 | -0.098700 | 1.08e-01 |
IRON UPTAKE AND TRANSPORT | 52 | 2.20e-01 | 0.098300 | 4.54e-01 |
EGFR DOWNREGULATION | 28 | 3.70e-01 | -0.098000 | 6.15e-01 |
INFLAMMASOMES | 19 | 4.61e-01 | -0.097600 | 6.96e-01 |
CONDENSATION OF PROPHASE CHROMOSOMES | 27 | 3.80e-01 | -0.097600 | 6.21e-01 |
SIGNALING BY ERBB4 | 57 | 2.04e-01 | -0.097300 | 4.35e-01 |
SEMAPHORIN INTERACTIONS | 64 | 1.79e-01 | -0.097200 | 4.03e-01 |
ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 5.77e-01 | -0.097000 | 7.79e-01 |
MEIOSIS | 64 | 1.80e-01 | -0.096800 | 4.04e-01 |
ESR MEDIATED SIGNALING | 166 | 3.24e-02 | -0.096300 | 1.48e-01 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 40 | 2.93e-01 | 0.096000 | 5.42e-01 |
PYRIMIDINE SALVAGE | 10 | 5.99e-01 | 0.096000 | 7.92e-01 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 59 | 2.04e-01 | 0.095700 | 4.35e-01 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 33 | 3.45e-01 | 0.095100 | 5.93e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1220 | 2.98e-08 | 0.095000 | 1.67e-06 |
REGULATION OF IFNG SIGNALING | 13 | 5.53e-01 | 0.094900 | 7.61e-01 |
SIGNALING BY NOTCH4 | 83 | 1.37e-01 | -0.094400 | 3.51e-01 |
OTHER INTERLEUKIN SIGNALING | 20 | 4.65e-01 | 0.094400 | 6.99e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 79 | 1.48e-01 | 0.094200 | 3.64e-01 |
NUCLEOTIDE SALVAGE | 21 | 4.56e-01 | 0.093900 | 6.92e-01 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 12 | 5.75e-01 | 0.093600 | 7.76e-01 |
GENE SILENCING BY RNA | 84 | 1.38e-01 | -0.093600 | 3.53e-01 |
TELOMERE EXTENSION BY TELOMERASE | 22 | 4.49e-01 | -0.093200 | 6.84e-01 |
SENSORY PROCESSING OF SOUND | 60 | 2.12e-01 | 0.093200 | 4.47e-01 |
DNA STRAND ELONGATION | 32 | 3.64e-01 | 0.092800 | 6.09e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 4.84e-01 | 0.092700 | 7.13e-01 |
REGULATION OF BACH1 ACTIVITY | 11 | 5.96e-01 | -0.092400 | 7.90e-01 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 30 | 3.81e-01 | -0.092400 | 6.21e-01 |
CRMPS IN SEMA3A SIGNALING | 16 | 5.24e-01 | 0.092000 | 7.41e-01 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 65 | 2.00e-01 | -0.091900 | 4.30e-01 |
MITOTIC PROMETAPHASE | 180 | 3.36e-02 | 0.091900 | 1.49e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 4.30e-01 | -0.091300 | 6.63e-01 |
PTEN REGULATION | 136 | 6.76e-02 | -0.090800 | 2.21e-01 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 5.86e-01 | -0.090700 | 7.85e-01 |
SIGNALING BY SCF KIT | 41 | 3.15e-01 | 0.090700 | 5.62e-01 |
FRS MEDIATED FGFR2 SIGNALING | 18 | 5.06e-01 | 0.090600 | 7.32e-01 |
METABOLISM OF STEROIDS | 118 | 8.96e-02 | 0.090500 | 2.64e-01 |
GPCR LIGAND BINDING | 276 | 9.83e-03 | -0.090400 | 7.69e-02 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 6.05e-01 | -0.090000 | 7.94e-01 |
GLYCOGEN STORAGE DISEASES | 12 | 5.90e-01 | 0.089800 | 7.88e-01 |
MITOTIC SPINDLE CHECKPOINT | 100 | 1.21e-01 | 0.089800 | 3.24e-01 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 3.21e-01 | 0.089500 | 5.67e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 6.08e-01 | -0.089300 | 7.94e-01 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 4.69e-01 | 0.089200 | 7.00e-01 |
THE NLRP3 INFLAMMASOME | 15 | 5.50e-01 | -0.089100 | 7.61e-01 |
SIGNALING BY ACTIVIN | 12 | 5.93e-01 | -0.089000 | 7.89e-01 |
PEROXISOMAL PROTEIN IMPORT | 60 | 2.34e-01 | 0.088800 | 4.70e-01 |
RHOBTB1 GTPASE CYCLE | 23 | 4.61e-01 | -0.088700 | 6.96e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 86 | 1.56e-01 | 0.088600 | 3.73e-01 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 4.72e-01 | -0.088500 | 7.02e-01 |
INTEGRATION OF ENERGY METABOLISM | 98 | 1.30e-01 | 0.088500 | 3.41e-01 |
ACTIVATION OF PPARGC1A PGC 1ALPHA BY PHOSPHORYLATION | 10 | 6.29e-01 | 0.088200 | 8.06e-01 |
PLATELET HOMEOSTASIS | 79 | 1.75e-01 | 0.088200 | 3.98e-01 |
CIRCADIAN CLOCK | 68 | 2.12e-01 | 0.087700 | 4.47e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 92 | 1.47e-01 | 0.087500 | 3.64e-01 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 25 | 4.50e-01 | -0.087400 | 6.84e-01 |
SIGNALING BY NOTCH1 | 75 | 1.93e-01 | -0.087000 | 4.22e-01 |
SIGNALING BY ERYTHROPOIETIN | 24 | 4.67e-01 | 0.085800 | 7.00e-01 |
FORMATION OF APOPTOSOME | 10 | 6.39e-01 | 0.085700 | 8.11e-01 |
GABA RECEPTOR ACTIVATION | 55 | 2.72e-01 | 0.085600 | 5.16e-01 |
ELASTIC FIBRE FORMATION | 39 | 3.60e-01 | 0.084800 | 6.05e-01 |
PROLACTIN RECEPTOR SIGNALING | 12 | 6.11e-01 | 0.084800 | 7.95e-01 |
AUTOPHAGY | 139 | 8.48e-02 | 0.084700 | 2.56e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 88 | 1.71e-01 | -0.084500 | 3.92e-01 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 54 | 2.85e-01 | -0.084100 | 5.32e-01 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 5.17e-01 | 0.083800 | 7.35e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 4.28e-01 | 0.083700 | 6.62e-01 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 5.54e-01 | 0.083000 | 7.61e-01 |
DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 6.05e-01 | 0.082900 | 7.93e-01 |
TCR SIGNALING | 101 | 1.50e-01 | -0.082900 | 3.64e-01 |
RHOJ GTPASE CYCLE | 55 | 2.88e-01 | 0.082800 | 5.35e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 14 | 5.93e-01 | 0.082600 | 7.89e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 6.51e-01 | -0.082600 | 8.20e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 3.87e-01 | -0.082200 | 6.25e-01 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 5.95e-01 | 0.082000 | 7.90e-01 |
CELLULAR RESPONSE TO HEAT STRESS | 96 | 1.65e-01 | -0.082000 | 3.85e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 2.57e-01 | 0.081900 | 5.00e-01 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 5.84e-01 | 0.081700 | 7.83e-01 |
HEMOSTASIS | 482 | 2.21e-03 | 0.081600 | 2.71e-02 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 63 | 2.63e-01 | -0.081600 | 5.09e-01 |
FCERI MEDIATED NF KB ACTIVATION | 78 | 2.15e-01 | -0.081300 | 4.49e-01 |
NETRIN 1 SIGNALING | 50 | 3.21e-01 | 0.081200 | 5.67e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 17 | 5.63e-01 | 0.081100 | 7.67e-01 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 38 | 3.88e-01 | -0.081000 | 6.25e-01 |
METABOLISM OF POLYAMINES | 58 | 2.88e-01 | -0.080800 | 5.34e-01 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 322 | 1.32e-02 | -0.080500 | 8.85e-02 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 67 | 2.56e-01 | -0.080300 | 4.98e-01 |
FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 6.62e-01 | 0.079700 | 8.24e-01 |
PKMTS METHYLATE HISTONE LYSINES | 47 | 3.46e-01 | -0.079500 | 5.93e-01 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 3.41e-01 | -0.079500 | 5.90e-01 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 3.73e-01 | -0.079400 | 6.16e-01 |
INTERLEUKIN 15 SIGNALING | 13 | 6.21e-01 | 0.079300 | 8.01e-01 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 24 | 5.02e-01 | -0.079200 | 7.29e-01 |
P38MAPK EVENTS | 13 | 6.21e-01 | 0.079100 | 8.01e-01 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 79 | 2.25e-01 | -0.079100 | 4.58e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 5.74e-01 | -0.078800 | 7.76e-01 |
MET ACTIVATES PTK2 SIGNALING | 28 | 4.71e-01 | -0.078700 | 7.01e-01 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 5.14e-01 | -0.078600 | 7.34e-01 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 6.12e-01 | 0.078400 | 7.95e-01 |
RHO GTPASES ACTIVATE FORMINS | 122 | 1.36e-01 | 0.078300 | 3.48e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 633 | 8.87e-04 | 0.077700 | 1.42e-02 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 6.03e-01 | 0.077600 | 7.93e-01 |
PROTEIN UBIQUITINATION | 70 | 2.64e-01 | -0.077300 | 5.09e-01 |
DEVELOPMENTAL BIOLOGY | 832 | 1.68e-04 | -0.077200 | 3.67e-03 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 39 | 4.05e-01 | 0.077000 | 6.41e-01 |
RET SIGNALING | 37 | 4.20e-01 | 0.076600 | 6.57e-01 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 3.91e-01 | -0.076500 | 6.30e-01 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 25 | 5.08e-01 | -0.076500 | 7.33e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 5.55e-01 | 0.076300 | 7.61e-01 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 77 | 2.48e-01 | -0.076200 | 4.87e-01 |
METABOLISM OF VITAMINS AND COFACTORS | 155 | 1.06e-01 | 0.075400 | 2.96e-01 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 5.51e-01 | -0.075200 | 7.61e-01 |
REGULATION OF KIT SIGNALING | 16 | 6.03e-01 | 0.075100 | 7.93e-01 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 13 | 6.40e-01 | -0.075000 | 8.11e-01 |
EXTENSION OF TELOMERES | 49 | 3.64e-01 | -0.075000 | 6.09e-01 |
INTERLEUKIN 12 SIGNALING | 36 | 4.37e-01 | -0.074900 | 6.69e-01 |
PLASMA LIPOPROTEIN CLEARANCE | 26 | 5.11e-01 | 0.074400 | 7.34e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 21 | 5.55e-01 | 0.074400 | 7.61e-01 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 6.57e-01 | 0.074000 | 8.21e-01 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 6.09e-01 | 0.073900 | 7.94e-01 |
SMOOTH MUSCLE CONTRACTION | 32 | 4.69e-01 | -0.073900 | 7.00e-01 |
SIGNALING BY FGFR IN DISEASE | 55 | 3.48e-01 | -0.073200 | 5.95e-01 |
COSTIMULATION BY THE CD28 FAMILY | 49 | 3.77e-01 | 0.073000 | 6.19e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 97 | 2.15e-01 | -0.072800 | 4.49e-01 |
RHO GTPASE CYCLE | 427 | 1.04e-02 | 0.072500 | 7.84e-02 |
LYSOSOME VESICLE BIOGENESIS | 33 | 4.71e-01 | 0.072500 | 7.01e-01 |
ARACHIDONIC ACID METABOLISM | 41 | 4.23e-01 | 0.072400 | 6.59e-01 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 5.57e-01 | 0.072400 | 7.62e-01 |
RND2 GTPASE CYCLE | 39 | 4.35e-01 | -0.072200 | 6.68e-01 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 48 | 3.88e-01 | 0.072100 | 6.25e-01 |
RND3 GTPASE CYCLE | 39 | 4.36e-01 | -0.072100 | 6.69e-01 |
RHO GTPASE EFFECTORS | 252 | 5.01e-02 | 0.071800 | 1.85e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 6.55e-01 | 0.071700 | 8.21e-01 |
SIGNALING BY NTRK3 TRKC | 17 | 6.13e-01 | -0.070800 | 7.95e-01 |
CROSSLINKING OF COLLAGEN FIBRILS | 17 | 6.14e-01 | -0.070800 | 7.95e-01 |
HOMOLOGY DIRECTED REPAIR | 105 | 2.12e-01 | -0.070500 | 4.47e-01 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 5.87e-01 | 0.070100 | 7.85e-01 |
RHO GTPASES ACTIVATE IQGAPS | 24 | 5.53e-01 | 0.070000 | 7.61e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 5.54e-01 | -0.069800 | 7.61e-01 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 5.54e-01 | -0.069800 | 7.61e-01 |
CD209 DC SIGN SIGNALING | 18 | 6.09e-01 | 0.069700 | 7.94e-01 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 7.04e-01 | 0.069300 | 8.50e-01 |
DISEASES OF CARBOHYDRATE METABOLISM | 29 | 5.21e-01 | 0.068800 | 7.38e-01 |
PERK REGULATES GENE EXPRESSION | 28 | 5.29e-01 | -0.068800 | 7.44e-01 |
PROCESSING OF SMDT1 | 16 | 6.35e-01 | 0.068500 | 8.11e-01 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 87 | 2.70e-01 | -0.068400 | 5.14e-01 |
NEGATIVE REGULATION OF FLT3 | 14 | 6.58e-01 | -0.068400 | 8.21e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 60 | 3.62e-01 | -0.068100 | 6.08e-01 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 64 | 3.46e-01 | -0.068100 | 5.94e-01 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 6.49e-01 | 0.067900 | 8.20e-01 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 7.10e-01 | -0.067900 | 8.52e-01 |
METABOLISM OF STEROID HORMONES | 22 | 5.83e-01 | -0.067700 | 7.83e-01 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 6.29e-01 | -0.067700 | 8.06e-01 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 25 | 5.58e-01 | 0.067600 | 7.63e-01 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 6.75e-01 | -0.067200 | 8.29e-01 |
INITIAL TRIGGERING OF COMPLEMENT | 13 | 6.77e-01 | -0.066800 | 8.30e-01 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 5.48e-01 | -0.066800 | 7.61e-01 |
DISEASES OF PROGRAMMED CELL DEATH | 53 | 4.03e-01 | -0.066500 | 6.40e-01 |
INTERLEUKIN 12 FAMILY SIGNALING | 42 | 4.58e-01 | -0.066100 | 6.94e-01 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 4.81e-01 | 0.066000 | 7.12e-01 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 6.58e-01 | 0.066000 | 8.21e-01 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 4.03e-01 | 0.065900 | 6.40e-01 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 6.70e-01 | -0.065800 | 8.26e-01 |
METABOLISM OF NUCLEOTIDES | 92 | 2.77e-01 | 0.065700 | 5.20e-01 |
REGULATION OF BETA CELL DEVELOPMENT | 29 | 5.47e-01 | 0.064700 | 7.61e-01 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 6.87e-01 | 0.064500 | 8.38e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 62 | 3.82e-01 | -0.064200 | 6.21e-01 |
PEXOPHAGY | 11 | 7.13e-01 | -0.064000 | 8.54e-01 |
DUAL INCISION IN GG NER | 40 | 4.86e-01 | -0.063700 | 7.14e-01 |
SIGNALING BY PTK6 | 52 | 4.28e-01 | 0.063600 | 6.62e-01 |
HIV LIFE CYCLE | 142 | 1.92e-01 | -0.063500 | 4.21e-01 |
CALNEXIN CALRETICULIN CYCLE | 26 | 5.79e-01 | -0.062900 | 7.80e-01 |
HIV INFECTION | 222 | 1.07e-01 | -0.062800 | 2.99e-01 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 27 | 5.73e-01 | 0.062600 | 7.76e-01 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 22 | 6.12e-01 | -0.062500 | 7.95e-01 |
SURFACTANT METABOLISM | 16 | 6.67e-01 | -0.062100 | 8.26e-01 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 5.19e-01 | -0.062100 | 7.36e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 282 | 7.33e-02 | 0.062100 | 2.30e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 27 | 5.80e-01 | 0.061500 | 7.81e-01 |
INTRAFLAGELLAR TRANSPORT | 51 | 4.49e-01 | -0.061300 | 6.84e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 224 | 1.15e-01 | 0.061300 | 3.15e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 32 | 5.50e-01 | 0.061100 | 7.61e-01 |
DNA REPLICATION PRE INITIATION | 80 | 3.46e-01 | -0.061000 | 5.93e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 4.90e-01 | -0.060900 | 7.18e-01 |
SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 7.09e-01 | 0.059900 | 8.52e-01 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 4.97e-01 | 0.059900 | 7.24e-01 |
SIGNALING BY INTERLEUKINS | 353 | 5.41e-02 | 0.059800 | 1.93e-01 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 84 | 3.46e-01 | -0.059600 | 5.93e-01 |
INTERLEUKIN 37 SIGNALING | 18 | 6.64e-01 | 0.059100 | 8.26e-01 |
FGFR2 LIGAND BINDING AND ACTIVATION | 12 | 7.25e-01 | 0.058600 | 8.59e-01 |
GLUTATHIONE CONJUGATION | 29 | 5.87e-01 | -0.058300 | 7.85e-01 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 6.96e-01 | -0.058300 | 8.47e-01 |
INTERLEUKIN 2 FAMILY SIGNALING | 33 | 5.62e-01 | 0.058300 | 7.67e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 6.97e-01 | 0.058100 | 8.47e-01 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 22 | 6.38e-01 | -0.057900 | 8.11e-01 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 6.71e-01 | 0.057900 | 8.26e-01 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 43 | 5.12e-01 | -0.057800 | 7.34e-01 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 6.72e-01 | -0.057600 | 8.27e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 466 | 3.36e-02 | 0.057600 | 1.49e-01 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 6.33e-01 | 0.057500 | 8.10e-01 |
DNA REPLICATION | 122 | 2.73e-01 | -0.057500 | 5.16e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 46 | 5.00e-01 | 0.057400 | 7.28e-01 |
RUNX2 REGULATES BONE DEVELOPMENT | 28 | 6.03e-01 | -0.056700 | 7.93e-01 |
SARS COV INFECTIONS | 140 | 2.54e-01 | -0.055900 | 4.95e-01 |
SIGNALING BY MET | 75 | 4.04e-01 | 0.055800 | 6.40e-01 |
DAP12 INTERACTIONS | 31 | 5.92e-01 | -0.055600 | 7.89e-01 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 7.00e-01 | 0.055600 | 8.50e-01 |
CELLULAR SENESCENCE | 140 | 2.59e-01 | -0.055300 | 5.03e-01 |
METABOLISM OF FAT SOLUBLE VITAMINS | 33 | 5.83e-01 | -0.055200 | 7.83e-01 |
INNATE IMMUNE SYSTEM | 797 | 8.39e-03 | 0.055200 | 7.02e-02 |
DNA DOUBLE STRAND BREAK REPAIR | 134 | 2.73e-01 | -0.054900 | 5.16e-01 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 75 | 4.13e-01 | -0.054700 | 6.47e-01 |
TRIGLYCERIDE CATABOLISM | 14 | 7.27e-01 | -0.053900 | 8.60e-01 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 5.15e-01 | -0.053800 | 7.34e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 33 | 5.94e-01 | -0.053700 | 7.89e-01 |
MAPK FAMILY SIGNALING CASCADES | 287 | 1.20e-01 | 0.053400 | 3.22e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 6.58e-01 | 0.053400 | 8.21e-01 |
HEDGEHOG ON STATE | 83 | 4.01e-01 | -0.053300 | 6.40e-01 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 6.80e-01 | -0.053300 | 8.32e-01 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 21 | 6.75e-01 | -0.052900 | 8.29e-01 |
SIGNALING BY ERBB2 | 48 | 5.28e-01 | -0.052700 | 7.44e-01 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 6.69e-01 | 0.052600 | 8.26e-01 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 11 | 7.64e-01 | 0.052400 | 8.77e-01 |
PCP CE PATHWAY | 90 | 3.93e-01 | -0.052100 | 6.31e-01 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 4.08e-01 | 0.051900 | 6.43e-01 |
VISUAL PHOTOTRANSDUCTION | 60 | 4.88e-01 | -0.051800 | 7.15e-01 |
GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 6.08e-01 | 0.051600 | 7.94e-01 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 7.22e-01 | 0.051500 | 8.59e-01 |
HYALURONAN UPTAKE AND DEGRADATION | 12 | 7.58e-01 | 0.051300 | 8.76e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 57 | 5.03e-01 | -0.051300 | 7.29e-01 |
ENOS ACTIVATION | 11 | 7.69e-01 | -0.051100 | 8.80e-01 |
MUSCLE CONTRACTION | 159 | 2.67e-01 | 0.051100 | 5.12e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 36 | 5.98e-01 | 0.050800 | 7.92e-01 |
SIGNALING BY EGFR | 47 | 5.49e-01 | -0.050500 | 7.61e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 7.44e-01 | 0.050500 | 8.68e-01 |
PLASMA LIPOPROTEIN ASSEMBLY | 12 | 7.63e-01 | 0.050400 | 8.77e-01 |
HEDGEHOG OFF STATE | 107 | 3.71e-01 | -0.050100 | 6.15e-01 |
PROTEIN LOCALIZATION | 159 | 2.76e-01 | 0.050100 | 5.20e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 6.03e-01 | 0.050100 | 7.93e-01 |
SENSORY PERCEPTION | 148 | 2.94e-01 | -0.050000 | 5.42e-01 |
SIGNALING BY NTRK2 TRKB | 25 | 6.66e-01 | 0.049900 | 8.26e-01 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 83 | 4.34e-01 | -0.049700 | 6.68e-01 |
TRANSLESION SYNTHESIS BY POLH | 19 | 7.08e-01 | -0.049700 | 8.52e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 7.09e-01 | 0.049500 | 8.52e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 6.40e-01 | -0.049400 | 8.11e-01 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 7.58e-01 | -0.049400 | 8.76e-01 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 7.87e-01 | 0.049400 | 8.88e-01 |
INWARDLY RECTIFYING K CHANNELS | 32 | 6.29e-01 | 0.049400 | 8.06e-01 |
HOST INTERACTIONS OF HIV FACTORS | 126 | 3.39e-01 | -0.049300 | 5.90e-01 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 7.42e-01 | 0.049000 | 8.68e-01 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 61 | 5.11e-01 | -0.048700 | 7.34e-01 |
SIGNALING BY FGFR4 | 31 | 6.39e-01 | 0.048700 | 8.11e-01 |
SNRNP ASSEMBLY | 51 | 5.48e-01 | -0.048600 | 7.61e-01 |
CA2 PATHWAY | 58 | 5.25e-01 | 0.048200 | 7.42e-01 |
GROWTH HORMONE RECEPTOR SIGNALING | 21 | 7.02e-01 | -0.048200 | 8.50e-01 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 5.09e-01 | -0.048200 | 7.33e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 25 | 6.78e-01 | 0.048000 | 8.31e-01 |
DUAL INCISION IN TC NER | 64 | 5.11e-01 | -0.047500 | 7.34e-01 |
DSCAM INTERACTIONS | 11 | 7.86e-01 | -0.047300 | 8.88e-01 |
BIOLOGICAL OXIDATIONS | 128 | 3.58e-01 | 0.047100 | 6.04e-01 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 61 | 5.28e-01 | 0.046700 | 7.44e-01 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 6.84e-01 | 0.046200 | 8.36e-01 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 5.60e-01 | -0.045400 | 7.65e-01 |
PRE NOTCH EXPRESSION AND PROCESSING | 62 | 5.37e-01 | -0.045300 | 7.53e-01 |
FOXO MEDIATED TRANSCRIPTION | 59 | 5.47e-01 | 0.045300 | 7.61e-01 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 33 | 6.53e-01 | 0.045200 | 8.21e-01 |
PYRIMIDINE CATABOLISM | 10 | 8.05e-01 | 0.045100 | 9.01e-01 |
G ALPHA Z SIGNALLING EVENTS | 45 | 6.02e-01 | -0.044900 | 7.93e-01 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 13 | 7.79e-01 | 0.044900 | 8.88e-01 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 7.42e-01 | 0.044800 | 8.68e-01 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 6.27e-01 | -0.044400 | 8.06e-01 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 38 | 6.36e-01 | -0.044400 | 8.11e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 6.86e-01 | 0.044100 | 8.38e-01 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 7.14e-01 | 0.044100 | 8.54e-01 |
HCMV LATE EVENTS | 64 | 5.43e-01 | 0.044000 | 7.61e-01 |
CHOLESTEROL BIOSYNTHESIS | 24 | 7.10e-01 | -0.043800 | 8.52e-01 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 7.20e-01 | -0.043100 | 8.59e-01 |
NEUTROPHIL DEGRANULATION | 397 | 1.45e-01 | 0.042700 | 3.62e-01 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 20 | 7.44e-01 | -0.042100 | 8.68e-01 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 6.29e-01 | -0.042100 | 8.06e-01 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 28 | 7.02e-01 | 0.041800 | 8.50e-01 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 7.41e-01 | 0.041700 | 8.68e-01 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 55 | 5.93e-01 | 0.041600 | 7.89e-01 |
MISMATCH REPAIR | 14 | 7.88e-01 | 0.041600 | 8.88e-01 |
TIE2 SIGNALING | 17 | 7.69e-01 | 0.041100 | 8.80e-01 |
ANCHORING FIBRIL FORMATION | 15 | 7.84e-01 | 0.040800 | 8.88e-01 |
RETINOID CYCLE DISEASE EVENTS | 10 | 8.23e-01 | -0.040800 | 9.09e-01 |
SIGNALING BY FGFR1 | 43 | 6.44e-01 | 0.040700 | 8.15e-01 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 8.24e-01 | 0.040500 | 9.09e-01 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 50 | 6.21e-01 | 0.040400 | 8.01e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 178 | 3.54e-01 | -0.040300 | 6.01e-01 |
METALLOPROTEASE DUBS | 26 | 7.23e-01 | -0.040200 | 8.59e-01 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 7.69e-01 | -0.039900 | 8.80e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 7.82e-01 | 0.039900 | 8.88e-01 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 7.58e-01 | -0.039800 | 8.76e-01 |
ACYL CHAIN REMODELLING OF PG | 11 | 8.19e-01 | 0.039800 | 9.09e-01 |
SIGNALING BY NUCLEAR RECEPTORS | 225 | 3.04e-01 | -0.039800 | 5.51e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 98 | 4.96e-01 | 0.039800 | 7.24e-01 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 7.59e-01 | -0.039600 | 8.77e-01 |
RHOQ GTPASE CYCLE | 58 | 6.06e-01 | 0.039200 | 7.94e-01 |
PECAM1 INTERACTIONS | 12 | 8.15e-01 | 0.039000 | 9.09e-01 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 7.48e-01 | 0.038800 | 8.71e-01 |
SIGNALING BY HEDGEHOG | 142 | 4.27e-01 | -0.038600 | 6.62e-01 |
SIGNALING BY GPCR | 494 | 1.44e-01 | 0.038500 | 3.61e-01 |
CILIUM ASSEMBLY | 192 | 3.59e-01 | -0.038400 | 6.05e-01 |
LAGGING STRAND SYNTHESIS | 20 | 7.66e-01 | -0.038400 | 8.79e-01 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 7.55e-01 | 0.038400 | 8.76e-01 |
SARS COV 1 INFECTION | 48 | 6.46e-01 | 0.038400 | 8.16e-01 |
NGF STIMULATED TRANSCRIPTION | 36 | 6.91e-01 | -0.038300 | 8.42e-01 |
REGULATION OF GENE EXPRESSION IN BETA CELLS | 11 | 8.27e-01 | 0.038000 | 9.09e-01 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 90 | 5.34e-01 | 0.038000 | 7.50e-01 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 7.87e-01 | -0.037900 | 8.88e-01 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 5.49e-01 | -0.037900 | 7.61e-01 |
SYNDECAN INTERACTIONS | 26 | 7.38e-01 | -0.037900 | 8.68e-01 |
KINESINS | 48 | 6.50e-01 | 0.037800 | 8.20e-01 |
CHROMATIN MODIFYING ENZYMES | 218 | 3.37e-01 | -0.037800 | 5.88e-01 |
ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 8.36e-01 | 0.037800 | 9.11e-01 |
SIGNALING BY FGFR3 | 34 | 7.03e-01 | 0.037800 | 8.50e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 6.62e-01 | 0.037700 | 8.24e-01 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 6.69e-01 | 0.037700 | 8.26e-01 |
M PHASE | 343 | 2.33e-01 | 0.037500 | 4.70e-01 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 77 | 5.73e-01 | -0.037200 | 7.76e-01 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 7.44e-01 | -0.037000 | 8.68e-01 |
CELL CYCLE MITOTIC | 478 | 1.69e-01 | 0.036900 | 3.90e-01 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 6.69e-01 | 0.036800 | 8.26e-01 |
REGULATION OF TP53 ACTIVITY | 154 | 4.31e-01 | 0.036800 | 6.65e-01 |
SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 7.73e-01 | 0.036400 | 8.84e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 12 | 8.28e-01 | -0.036200 | 9.09e-01 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 7.11e-01 | -0.036200 | 8.52e-01 |
PI 3K CASCADE FGFR2 | 16 | 8.03e-01 | 0.036000 | 9.00e-01 |
RHOD GTPASE CYCLE | 51 | 6.57e-01 | 0.035900 | 8.21e-01 |
LAMININ INTERACTIONS | 29 | 7.38e-01 | -0.035900 | 8.68e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 285 | 3.05e-01 | -0.035400 | 5.51e-01 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 8.48e-01 | -0.035100 | 9.17e-01 |
SIGNALING BY FGFR1 IN DISEASE | 32 | 7.32e-01 | 0.035000 | 8.64e-01 |
IRE1ALPHA ACTIVATES CHAPERONES | 50 | 6.69e-01 | 0.034900 | 8.26e-01 |
HATS ACETYLATE HISTONES | 92 | 5.64e-01 | -0.034800 | 7.67e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 8.16e-01 | 0.034700 | 9.09e-01 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 8.29e-01 | 0.034500 | 9.09e-01 |
SIGNALING BY CSF3 G CSF | 29 | 7.51e-01 | 0.034100 | 8.73e-01 |
EPHRIN SIGNALING | 19 | 7.98e-01 | 0.034000 | 8.97e-01 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 8.47e-01 | 0.033600 | 9.17e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 7.40e-01 | -0.033400 | 8.68e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 8.42e-01 | -0.033200 | 9.16e-01 |
RND1 GTPASE CYCLE | 39 | 7.22e-01 | 0.032900 | 8.59e-01 |
PHASE II CONJUGATION OF COMPOUNDS | 63 | 6.54e-01 | 0.032700 | 8.21e-01 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 74 | 6.27e-01 | 0.032700 | 8.06e-01 |
TP53 REGULATES METABOLIC GENES | 87 | 6.00e-01 | -0.032600 | 7.92e-01 |
LEISHMANIA INFECTION | 204 | 4.24e-01 | 0.032500 | 6.59e-01 |
DNA REPAIR | 290 | 3.45e-01 | -0.032300 | 5.93e-01 |
G ALPHA S SIGNALLING EVENTS | 110 | 5.64e-01 | -0.031900 | 7.67e-01 |
NICOTINATE METABOLISM | 25 | 7.84e-01 | 0.031600 | 8.88e-01 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 13 | 8.44e-01 | -0.031500 | 9.16e-01 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 7.95e-01 | -0.031300 | 8.95e-01 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 7.60e-01 | -0.031200 | 8.77e-01 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 39 | 7.37e-01 | -0.031100 | 8.68e-01 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 7.62e-01 | 0.030900 | 8.77e-01 |
INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 7.04e-01 | 0.030500 | 8.50e-01 |
EPH EPHRIN SIGNALING | 91 | 6.21e-01 | -0.030000 | 8.01e-01 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 8.28e-01 | 0.029600 | 9.09e-01 |
N GLYCAN ANTENNAE ELONGATION | 15 | 8.44e-01 | 0.029400 | 9.16e-01 |
REGULATION OF PTEN GENE TRANSCRIPTION | 59 | 7.03e-01 | -0.028700 | 8.50e-01 |
MITOCHONDRIAL BIOGENESIS | 93 | 6.37e-01 | -0.028300 | 8.11e-01 |
INTERLEUKIN 10 SIGNALING | 21 | 8.23e-01 | 0.028200 | 9.09e-01 |
SIGNALING BY PDGF | 57 | 7.17e-01 | 0.027800 | 8.56e-01 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 7.57e-01 | -0.027200 | 8.76e-01 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 364 | 3.76e-01 | 0.027100 | 6.18e-01 |
REGULATION OF TNFR1 SIGNALING | 34 | 7.86e-01 | -0.026900 | 8.88e-01 |
RHOH GTPASE CYCLE | 37 | 7.79e-01 | -0.026700 | 8.88e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 8.74e-01 | 0.026500 | 9.38e-01 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 22 | 8.31e-01 | -0.026300 | 9.09e-01 |
SPRY REGULATION OF FGF SIGNALING | 16 | 8.56e-01 | 0.026200 | 9.25e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 7.29e-01 | -0.026100 | 8.61e-01 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 11 | 8.81e-01 | -0.026100 | 9.43e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1101 | 1.48e-01 | -0.026000 | 3.64e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 23 | 8.29e-01 | 0.025900 | 9.09e-01 |
DAP12 SIGNALING | 24 | 8.27e-01 | -0.025700 | 9.09e-01 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 8.09e-01 | 0.025400 | 9.05e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 37 | 7.89e-01 | -0.025400 | 8.90e-01 |
ACYL CHAIN REMODELLING OF PS | 15 | 8.66e-01 | -0.025300 | 9.30e-01 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 8.31e-01 | -0.025200 | 9.09e-01 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 59 | 7.40e-01 | -0.025000 | 8.68e-01 |
NUCLEOTIDE EXCISION REPAIR | 109 | 6.56e-01 | -0.024700 | 8.21e-01 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 28 | 8.23e-01 | 0.024400 | 9.09e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 140 | 6.19e-01 | -0.024400 | 8.01e-01 |
ECM PROTEOGLYCANS | 67 | 7.32e-01 | -0.024200 | 8.64e-01 |
ACYL CHAIN REMODELLING OF PC | 17 | 8.63e-01 | -0.024100 | 9.29e-01 |
ACTIVATION OF BH3 ONLY PROTEINS | 30 | 8.22e-01 | 0.023800 | 9.09e-01 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 74 | 7.25e-01 | 0.023700 | 8.59e-01 |
FC EPSILON RECEPTOR FCERI SIGNALING | 125 | 6.52e-01 | 0.023400 | 8.20e-01 |
SELECTIVE AUTOPHAGY | 72 | 7.33e-01 | -0.023300 | 8.64e-01 |
GABA B RECEPTOR ACTIVATION | 40 | 8.03e-01 | 0.022900 | 9.00e-01 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 8.88e-01 | -0.022600 | 9.45e-01 |
RA BIOSYNTHESIS PATHWAY | 14 | 8.84e-01 | -0.022600 | 9.43e-01 |
SIGNAL TRANSDUCTION BY L1 | 21 | 8.65e-01 | 0.021400 | 9.30e-01 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 13 | 8.94e-01 | 0.021400 | 9.49e-01 |
RESOLUTION OF D LOOP STRUCTURES | 30 | 8.43e-01 | -0.020900 | 9.16e-01 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 8.97e-01 | 0.020800 | 9.51e-01 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 24 | 8.61e-01 | -0.020700 | 9.28e-01 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 9.06e-01 | 0.020500 | 9.53e-01 |
FANCONI ANEMIA PATHWAY | 37 | 8.32e-01 | 0.020100 | 9.09e-01 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 79 | 7.64e-01 | 0.019600 | 8.77e-01 |
TNF SIGNALING | 43 | 8.24e-01 | -0.019600 | 9.09e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 11 | 9.11e-01 | 0.019500 | 9.55e-01 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 8.36e-01 | 0.019500 | 9.11e-01 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 94 | 7.49e-01 | -0.019100 | 8.71e-01 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 8.03e-01 | 0.018700 | 9.00e-01 |
HCMV EARLY EVENTS | 79 | 7.82e-01 | -0.018100 | 8.88e-01 |
G PROTEIN BETA GAMMA SIGNALLING | 31 | 8.63e-01 | -0.017900 | 9.29e-01 |
NEGATIVE REGULATION OF MET ACTIVITY | 20 | 8.90e-01 | -0.017900 | 9.47e-01 |
DEUBIQUITINATION | 242 | 6.44e-01 | 0.017300 | 8.15e-01 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 9.08e-01 | -0.017200 | 9.53e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 8.48e-01 | -0.017100 | 9.17e-01 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 146 | 7.24e-01 | 0.016900 | 8.59e-01 |
KILLING MECHANISMS | 10 | 9.31e-01 | 0.015800 | 9.67e-01 |
MITOTIC G2 G2 M PHASES | 186 | 7.11e-01 | -0.015800 | 8.52e-01 |
PEPTIDE HORMONE METABOLISM | 63 | 8.30e-01 | -0.015600 | 9.09e-01 |
MITOTIC METAPHASE AND ANAPHASE | 211 | 6.97e-01 | 0.015600 | 8.47e-01 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 8.85e-01 | -0.015500 | 9.43e-01 |
REGULATION OF INSULIN SECRETION | 72 | 8.20e-01 | 0.015500 | 9.09e-01 |
SARS COV 2 INFECTION | 65 | 8.32e-01 | 0.015200 | 9.09e-01 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 9.04e-01 | -0.015200 | 9.53e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 9.29e-01 | -0.014900 | 9.66e-01 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 9.26e-01 | 0.014900 | 9.66e-01 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 9.32e-01 | -0.014800 | 9.67e-01 |
INTERLEUKIN 1 SIGNALING | 96 | 8.03e-01 | -0.014800 | 9.00e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 9.12e-01 | 0.014700 | 9.56e-01 |
G ALPHA I SIGNALLING EVENTS | 204 | 7.21e-01 | 0.014500 | 8.59e-01 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 18 | 9.16e-01 | -0.014400 | 9.59e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 54 | 8.57e-01 | -0.014200 | 9.25e-01 |
DEADENYLATION OF MRNA | 25 | 9.04e-01 | 0.014000 | 9.53e-01 |
ERBB2 REGULATES CELL MOTILITY | 14 | 9.29e-01 | 0.013700 | 9.66e-01 |
MET PROMOTES CELL MOTILITY | 39 | 8.84e-01 | 0.013500 | 9.43e-01 |
UNFOLDED PROTEIN RESPONSE UPR | 85 | 8.31e-01 | 0.013400 | 9.09e-01 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 142 | 7.85e-01 | 0.013300 | 8.88e-01 |
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN | 10 | 9.42e-01 | -0.013200 | 9.73e-01 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 9.34e-01 | 0.013200 | 9.67e-01 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 9.03e-01 | 0.012800 | 9.53e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 27 | 9.08e-01 | 0.012800 | 9.53e-01 |
KERATINIZATION | 27 | 9.08e-01 | 0.012800 | 9.53e-01 |
C TYPE LECTIN RECEPTORS CLRS | 114 | 8.14e-01 | -0.012800 | 9.09e-01 |
APOPTOSIS | 165 | 7.82e-01 | 0.012500 | 8.88e-01 |
NOD1 2 SIGNALING PATHWAY | 36 | 8.97e-01 | 0.012500 | 9.51e-01 |
UB SPECIFIC PROCESSING PROTEASES | 167 | 7.82e-01 | -0.012400 | 8.88e-01 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 9.00e-01 | -0.012400 | 9.52e-01 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 9.28e-01 | 0.012300 | 9.66e-01 |
HYALURONAN METABOLISM | 16 | 9.33e-01 | 0.012200 | 9.67e-01 |
SIGNALING BY THE B CELL RECEPTOR BCR | 105 | 8.32e-01 | -0.012000 | 9.09e-01 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 126 | 8.19e-01 | -0.011800 | 9.09e-01 |
CELL CYCLE CHECKPOINTS | 245 | 7.58e-01 | -0.011400 | 8.76e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 8.83e-01 | -0.011300 | 9.43e-01 |
BASIGIN INTERACTIONS | 22 | 9.29e-01 | 0.010900 | 9.66e-01 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 20 | 9.33e-01 | -0.010800 | 9.67e-01 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 14 | 9.44e-01 | 0.010800 | 9.73e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 554 | 6.68e-01 | 0.010700 | 8.26e-01 |
INTERLEUKIN 1 FAMILY SIGNALING | 123 | 8.45e-01 | 0.010200 | 9.16e-01 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 9.40e-01 | -0.009910 | 9.72e-01 |
ACTIVATION OF RAC1 | 13 | 9.52e-01 | 0.009700 | 9.78e-01 |
SIGNALING BY TGFB FAMILY MEMBERS | 97 | 8.78e-01 | -0.009000 | 9.40e-01 |
TRNA PROCESSING | 105 | 8.76e-01 | -0.008790 | 9.39e-01 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 9.38e-01 | -0.008690 | 9.70e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 9.43e-01 | -0.008620 | 9.73e-01 |
GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 9.54e-01 | -0.008550 | 9.79e-01 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 9.61e-01 | -0.008420 | 9.81e-01 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 83 | 8.98e-01 | -0.008130 | 9.51e-01 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 9.21e-01 | 0.007850 | 9.64e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 8.93e-01 | 0.007470 | 9.49e-01 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 9.64e-01 | -0.007220 | 9.82e-01 |
SUMOYLATION | 164 | 8.76e-01 | -0.007070 | 9.39e-01 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 109 | 9.01e-01 | 0.006910 | 9.52e-01 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 21 | 9.57e-01 | 0.006860 | 9.79e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 346 | 8.32e-01 | 0.006660 | 9.09e-01 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 9.62e-01 | 0.006400 | 9.82e-01 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 25 | 9.57e-01 | -0.006200 | 9.79e-01 |
GAP JUNCTION ASSEMBLY | 21 | 9.61e-01 | -0.006200 | 9.81e-01 |
METABOLISM OF FOLATE AND PTERINES | 15 | 9.69e-01 | -0.005880 | 9.85e-01 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 97 | 9.24e-01 | -0.005630 | 9.65e-01 |
SEPARATION OF SISTER CHROMATIDS | 170 | 9.01e-01 | -0.005560 | 9.52e-01 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 9.76e-01 | -0.005290 | 9.88e-01 |
AQUAPORIN MEDIATED TRANSPORT | 41 | 9.54e-01 | 0.005210 | 9.79e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 9.58e-01 | 0.004800 | 9.79e-01 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 9.65e-01 | -0.004750 | 9.83e-01 |
PHOSPHORYLATION OF THE APC C | 18 | 9.73e-01 | 0.004620 | 9.87e-01 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 9.49e-01 | -0.004350 | 9.77e-01 |
PROGRAMMED CELL DEATH | 187 | 9.23e-01 | 0.004110 | 9.64e-01 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 9.77e-01 | -0.003980 | 9.88e-01 |
MITOPHAGY | 29 | 9.71e-01 | -0.003840 | 9.87e-01 |
MET ACTIVATES RAP1 AND RAC1 | 10 | 9.84e-01 | -0.003690 | 9.95e-01 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 106 | 9.51e-01 | 0.003440 | 9.78e-01 |
RHOV GTPASE CYCLE | 33 | 9.73e-01 | 0.003380 | 9.87e-01 |
CLEC7A DECTIN 1 SIGNALING | 94 | 9.55e-01 | 0.003330 | 9.79e-01 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 9.86e-01 | -0.002270 | 9.96e-01 |
SIGNALING BY WNT | 269 | 9.70e-01 | -0.001350 | 9.86e-01 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 35 | 9.91e-01 | -0.001080 | 9.98e-01 |
LGI ADAM INTERACTIONS | 14 | 9.95e-01 | -0.000991 | 9.98e-01 |
G ALPHA Q SIGNALLING EVENTS | 163 | 9.88e-01 | 0.000662 | 9.98e-01 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 20 | 9.97e-01 | 0.000538 | 9.98e-01 |
S PHASE | 154 | 9.92e-01 | -0.000473 | 9.98e-01 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 9.95e-01 | 0.000445 | 9.98e-01 |
HCMV INFECTION | 102 | 9.94e-01 | -0.000433 | 9.98e-01 |
DNA DAMAGE BYPASS | 46 | 9.96e-01 | -0.000380 | 9.98e-01 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 22 | 9.98e-01 | -0.000368 | 9.98e-01 |
REPRESSION OF WNT TARGET GENES | 14 | 9.98e-01 | -0.000363 | 9.98e-01 |
CELL CYCLE | 595 | 9.90e-01 | -0.000308 | 9.98e-01 |
EXTRACELLULAR MATRIX ORGANIZATION | 248 | 9.97e-01 | 0.000149 | 9.98e-01 |
EUKARYOTIC TRANSLATION ELONGATION
306 | |
---|---|
set | EUKARYOTIC TRANSLATION ELONGATION |
setSize | 88 |
pANOVA | 5.9e-27 |
s.dist | -0.662 |
p.adjustANOVA | 3.48e-24 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Rps17 | -7426 |
Rps8 | -7421 |
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Rps17 | -7426 |
Rps8 | -7421 |
Rpl31 | -7250 |
Rplp1 | -7160 |
Rpl26 | -7071 |
Rps11 | -7053 |
Rps27a | -7027 |
Rpl24 | -7004 |
Rpl10a | -6880 |
Rpl36 | -6858 |
Rpl14 | -6787 |
Rps26 | -6585 |
Rpl29 | -6490 |
Rps7 | -6355 |
Rplp2 | -6350 |
Rps19 | -6333 |
Rpl22l1 | -6218 |
Rpl34 | -6199 |
Uba52 | -6187 |
Rpl32 | -6163 |
Rpl18 | -6160 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rpl28 | -5977 |
Rps16 | -5972 |
Rpl22 | -5905 |
Fau | -5890 |
Rps6 | -5794 |
Rpl19 | -5752 |
Rpl15 | -5718 |
Rps15a | -5694 |
Rpl11 | -5571 |
Rps24 | -5471 |
Eef1b2 | -5432 |
Rpl12 | -5252 |
Rps18 | -5182 |
Rpl13 | -5180 |
Rpl27a | -5162 |
Rpl4 | -5136 |
Rps5 | -4990 |
Rps9 | -4981 |
Eef1g | -4967 |
Rpl8 | -4888 |
Rps4x | -4846 |
Rpl3 | -4835 |
Rpl18a | -4813 |
Rps3a1 | -4631 |
Rpl6 | -4589 |
Rpl7 | -4400 |
Rps13 | -4263 |
Rpl27 | -4253 |
Rps27l | -4091 |
Rps2 | -4058 |
Rpl13a | -4006 |
Rpl17 | -3909 |
Rps14 | -3804 |
Rpsa | -3236 |
Rpl7a | -2903 |
Rpl9 | -2750 |
Rps10 | -2748 |
Eef1a1 | -1720 |
Rps3 | -1626 |
Eef1d | -1347 |
Rpl3l | -1143 |
Rpl5 | 46 |
Rplp0 | 1020 |
Rpl10 | 1911 |
Eef2 | 5948 |
Eef1a2 | 7108 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY
840 | |
---|---|
set | RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY |
setSize | 96 |
pANOVA | 1.03e-27 |
s.dist | -0.644 |
p.adjustANOVA | 1.21e-24 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Ddit3 | -8171 |
Rpl39 | -8168 |
Atf3 | -8143 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Ddit3 | -8171 |
Rpl39 | -8168 |
Atf3 | -8143 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Rps17 | -7426 |
Rps8 | -7421 |
Rpl31 | -7250 |
Rplp1 | -7160 |
Rpl26 | -7071 |
Rps11 | -7053 |
Rps27a | -7027 |
Rpl24 | -7004 |
Rpl10a | -6880 |
Rpl36 | -6858 |
Rpl14 | -6787 |
Rps26 | -6585 |
Rpl29 | -6490 |
Cebpg | -6486 |
Rps7 | -6355 |
Rplp2 | -6350 |
Rps19 | -6333 |
Eif2s2 | -6239 |
Rpl22l1 | -6218 |
Rpl34 | -6199 |
Uba52 | -6187 |
Rpl32 | -6163 |
Rpl18 | -6160 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rpl28 | -5977 |
Rps16 | -5972 |
Rpl22 | -5905 |
Fau | -5890 |
Rps6 | -5794 |
Rpl19 | -5752 |
Rpl15 | -5718 |
Rps15a | -5694 |
Rpl11 | -5571 |
Rps24 | -5471 |
Rpl12 | -5252 |
Rps18 | -5182 |
Rpl13 | -5180 |
Rpl27a | -5162 |
Rpl4 | -5136 |
Rps5 | -4990 |
Rps9 | -4981 |
Rpl8 | -4888 |
Rps4x | -4846 |
Rpl3 | -4835 |
Rpl18a | -4813 |
Impact | -4689 |
Rps3a1 | -4631 |
Rpl6 | -4589 |
Rpl7 | -4400 |
Trib3 | -4351 |
Rps13 | -4263 |
Rpl27 | -4253 |
Rps27l | -4091 |
Rps2 | -4058 |
Rpl13a | -4006 |
Rpl17 | -3909 |
Rps14 | -3804 |
Rpsa | -3236 |
Atf4 | -3007 |
Rpl7a | -2903 |
Rpl9 | -2750 |
Rps10 | -2748 |
Eif2ak4 | -2710 |
Rps3 | -1626 |
Rpl3l | -1143 |
Rpl5 | 46 |
Rplp0 | 1020 |
Cebpb | 1381 |
Eif2s3x | 1484 |
Rpl10 | 1911 |
Gcn1 | 2185 |
Eif2s1 | 3113 |
Asns | 3915 |
Atf2 | 4373 |
SCAVENGING OF HEME FROM PLASMA
911 | |
---|---|
set | SCAVENGING OF HEME FROM PLASMA |
setSize | 12 |
pANOVA | 0.000204 |
s.dist | 0.619 |
p.adjustANOVA | 0.00438 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Jchain | 8958 |
Igkv19-93 | 8911 |
Cd163 | 8808 |
Hbb-bt | 8655 |
Hba-a1 | 8646 |
Hba-a2 | 8344 |
Hp | 7261 |
Apol8 | 5812 |
Apol9a | 5786 |
Lrp1 | 5640 |
Apol7e | -1421 |
Apol10b | -6531 |
GeneID | Gene Rank |
---|---|
Jchain | 8958 |
Igkv19-93 | 8911 |
Cd163 | 8808 |
Hbb-bt | 8655 |
Hba-a1 | 8646 |
Hba-a2 | 8344 |
Hp | 7261 |
Apol8 | 5812 |
Apol9a | 5786 |
Lrp1 | 5640 |
Apol7e | -1421 |
Apol10b | -6531 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
1014 | |
---|---|
set | SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE |
setSize | 107 |
pANOVA | 1.56e-26 |
s.dist | -0.596 |
p.adjustANOVA | 6.15e-24 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Sec61b | -7445 |
Rps17 | -7426 |
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Sec61b | -7445 |
Rps17 | -7426 |
Rps8 | -7421 |
Rpn1 | -7356 |
Rpl31 | -7250 |
Rplp1 | -7160 |
Rpl26 | -7071 |
Rps11 | -7053 |
Rps27a | -7027 |
Rpl24 | -7004 |
Rpl10a | -6880 |
Rpl36 | -6858 |
Rpl14 | -6787 |
Rps26 | -6585 |
Rpl29 | -6490 |
Srp19 | -6412 |
Rps7 | -6355 |
Rplp2 | -6350 |
Rps19 | -6333 |
Rpl22l1 | -6218 |
Rpl34 | -6199 |
Uba52 | -6187 |
Rpl32 | -6163 |
Rpl18 | -6160 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rpl28 | -5977 |
Rps16 | -5972 |
Sec11c | -5958 |
Srp14 | -5955 |
Rpl22 | -5905 |
Fau | -5890 |
Rps6 | -5794 |
Rpl19 | -5752 |
Rpl15 | -5718 |
Rps15a | -5694 |
Rpl11 | -5571 |
Rps24 | -5471 |
Rpl12 | -5252 |
Ddost | -5204 |
Rps18 | -5182 |
Rpl13 | -5180 |
Rpl27a | -5162 |
Rpl4 | -5136 |
Spcs1 | -5121 |
Rps5 | -4990 |
Rps9 | -4981 |
Rpl8 | -4888 |
Rps4x | -4846 |
Rpl3 | -4835 |
Rpl18a | -4813 |
Rps3a1 | -4631 |
Rpl6 | -4589 |
Spcs2 | -4537 |
Rpl7 | -4400 |
Rps13 | -4263 |
Rpl27 | -4253 |
Rps27l | -4091 |
Rps2 | -4058 |
Rpl13a | -4006 |
Rpl17 | -3909 |
Rps14 | -3804 |
Sec11a | -3700 |
Rpsa | -3236 |
Ssr4 | -3161 |
Tram1 | -3121 |
Srprb | -3076 |
Srp54a | -2925 |
Rpl7a | -2903 |
Rpn2 | -2862 |
Rpl9 | -2750 |
Rps10 | -2748 |
Sec61a1 | -2532 |
Srp9 | -1958 |
Sec61a2 | -1704 |
Rps3 | -1626 |
Rpl3l | -1143 |
Ssr2 | -308 |
Rpl5 | 46 |
Rplp0 | 1020 |
Ssr1 | 1403 |
Srp72 | 1685 |
Rpl10 | 1911 |
Sec61g | 3698 |
Ssr3 | 4236 |
Srp68 | 7243 |
Srpr | 7427 |
Spcs3 | 7852 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS
4 | |
---|---|
set | ABC TRANSPORTERS IN LIPID HOMEOSTASIS |
setSize | 13 |
pANOVA | 0.000333 |
s.dist | 0.575 |
p.adjustANOVA | 0.00666 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Abca2 | 8768 |
Abca9 | 8688 |
Pex19 | 8280 |
Abca5 | 8188 |
Abcd3 | 7544 |
Abcg4 | 7379 |
Abca3 | 7024 |
Abca6 | 6191 |
Pex3 | 3435 |
Abca7 | 3202 |
Abcd2 | 3176 |
Abcd1 | 1839 |
Abcg1 | -4111 |
GeneID | Gene Rank |
---|---|
Abca2 | 8768 |
Abca9 | 8688 |
Pex19 | 8280 |
Abca5 | 8188 |
Abcd3 | 7544 |
Abcg4 | 7379 |
Abca3 | 7024 |
Abca6 | 6191 |
Pex3 | 3435 |
Abca7 | 3202 |
Abcd2 | 3176 |
Abcd1 | 1839 |
Abcg1 | -4111 |
ATTENUATION PHASE
85 | |
---|---|
set | ATTENUATION PHASE |
setSize | 25 |
pANOVA | 1.25e-06 |
s.dist | -0.56 |
p.adjustANOVA | 4.63e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Serpinh1 | -8229 |
Hspb1 | -7873 |
Crebbp | -7594 |
Hspa1b | -7483 |
Hsph1 | -7270 |
Fkbp4 | -7157 |
Hspa1a | -7112 |
Hsp90ab1 | -7101 |
Hspa8 | -6967 |
Hspa1l | -6846 |
Hsf1 | -6826 |
Hsp90aa1 | -6761 |
Ptges3 | -6622 |
Dnajb1 | -6438 |
Ubb | -5788 |
Hsbp1 | -4782 |
Dnajb6 | -4079 |
Hspa2 | -3690 |
Mrpl18 | -3308 |
Rln1 | -2003 |
GeneID | Gene Rank |
---|---|
Serpinh1 | -8229 |
Hspb1 | -7873 |
Crebbp | -7594 |
Hspa1b | -7483 |
Hsph1 | -7270 |
Fkbp4 | -7157 |
Hspa1a | -7112 |
Hsp90ab1 | -7101 |
Hspa8 | -6967 |
Hspa1l | -6846 |
Hsf1 | -6826 |
Hsp90aa1 | -6761 |
Ptges3 | -6622 |
Dnajb1 | -6438 |
Ubb | -5788 |
Hsbp1 | -4782 |
Dnajb6 | -4079 |
Hspa2 | -3690 |
Mrpl18 | -3308 |
Rln1 | -2003 |
Hspb2 | -1870 |
Col4a6 | 2570 |
Dedd2 | 3130 |
Tnfrsf21 | 4245 |
Ep300 | 4337 |
NONSENSE MEDIATED DECAY NMD
633 | |
---|---|
set | NONSENSE MEDIATED DECAY NMD |
setSize | 110 |
pANOVA | 4.85e-24 |
s.dist | -0.558 |
p.adjustANOVA | 1.15e-21 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Upf3b | -8113 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rbm8a | -7850 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Upf3b | -8113 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rbm8a | -7850 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Rps17 | -7426 |
Rps8 | -7421 |
Rpl31 | -7250 |
Rplp1 | -7160 |
Rpl26 | -7071 |
Rps11 | -7053 |
Rps27a | -7027 |
Rpl24 | -7004 |
Magohb | -6884 |
Rpl10a | -6880 |
Rpl36 | -6858 |
Rpl14 | -6787 |
Upf3a | -6603 |
Rps26 | -6585 |
Rpl29 | -6490 |
Rps7 | -6355 |
Rplp2 | -6350 |
Rps19 | -6333 |
Rpl22l1 | -6218 |
Ncbp2 | -6200 |
Rpl34 | -6199 |
Uba52 | -6187 |
Rpl32 | -6163 |
Rpl18 | -6160 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rpl28 | -5977 |
Rps16 | -5972 |
Rpl22 | -5905 |
Fau | -5890 |
Rps6 | -5794 |
Rpl19 | -5752 |
Rpl15 | -5718 |
Rps15a | -5694 |
Rpl11 | -5571 |
Rps24 | -5471 |
Eif4a3 | -5319 |
Rpl12 | -5252 |
Rps18 | -5182 |
Rpl13 | -5180 |
Rpl27a | -5162 |
Magoh | -5137 |
Rpl4 | -5136 |
Rps5 | -4990 |
Rps9 | -4981 |
Rpl8 | -4888 |
Rps4x | -4846 |
Rpl3 | -4835 |
Rpl18a | -4813 |
Rps3a1 | -4631 |
Rpl6 | -4589 |
Rpl7 | -4400 |
Upf2 | -4384 |
Rps13 | -4263 |
Rpl27 | -4253 |
Rps27l | -4091 |
Rps2 | -4058 |
Rpl13a | -4006 |
Rpl17 | -3909 |
Rps14 | -3804 |
Rpsa | -3236 |
Rpl7a | -2903 |
Rpl9 | -2750 |
Rps10 | -2748 |
Rnps1 | -2675 |
Ppp2r2a | -2550 |
Smg8 | -2382 |
Gspt2 | -1659 |
Rps3 | -1626 |
Rpl3l | -1143 |
Smg6 | -734 |
Pabpc1 | -661 |
Rpl5 | 46 |
Smg1 | 348 |
Smg9 | 362 |
Casc3 | 400 |
Etf1 | 798 |
Rplp0 | 1020 |
Ppp2ca | 1295 |
Rpl10 | 1911 |
Smg7 | 2446 |
Pnrc2 | 2489 |
Ncbp1 | 2649 |
Upf1 | 2843 |
Eif4g1 | 3132 |
Ppp2r1a | 3759 |
Gspt1 | 6993 |
Dcp1a | 7256 |
Smg5 | 8627 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE
1050 | |
---|---|
set | SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE |
setSize | 11 |
pANOVA | 0.00158 |
s.dist | 0.55 |
p.adjustANOVA | 0.0219 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fig4 | 8626 |
Mtmr2 | 8484 |
Pik3c2a | 8120 |
Pik3c3 | 7990 |
Vac14 | 7547 |
Mtmr7 | 7420 |
Mtmr4 | 4004 |
Mtmr9 | 2229 |
Pik3r4 | 1359 |
Pikfyve | 957 |
Mtm1 | -162 |
GeneID | Gene Rank |
---|---|
Fig4 | 8626 |
Mtmr2 | 8484 |
Pik3c2a | 8120 |
Pik3c3 | 7990 |
Vac14 | 7547 |
Mtmr7 | 7420 |
Mtmr4 | 4004 |
Mtmr9 | 2229 |
Pik3r4 | 1359 |
Pikfyve | 957 |
Mtm1 | -162 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX
816 | |
---|---|
set | REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX |
setSize | 15 |
pANOVA | 0.000437 |
s.dist | 0.524 |
p.adjustANOVA | 0.0082 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pdk2 | 8742 |
Pdk4 | 8402 |
Pdp2 | 7654 |
Pdhx | 7495 |
Rxra | 7400 |
Pdha1 | 7131 |
Pdpr | 6952 |
Dld | 6763 |
Ppard | 5492 |
Dlat | 5225 |
Pdp1 | 3897 |
Pdk3 | 3631 |
Pdhb | 1032 |
Pdk1 | -2709 |
Gstz1 | -3337 |
GeneID | Gene Rank |
---|---|
Pdk2 | 8742 |
Pdk4 | 8402 |
Pdp2 | 7654 |
Pdhx | 7495 |
Rxra | 7400 |
Pdha1 | 7131 |
Pdpr | 6952 |
Dld | 6763 |
Ppard | 5492 |
Dlat | 5225 |
Pdp1 | 3897 |
Pdk3 | 3631 |
Pdhb | 1032 |
Pdk1 | -2709 |
Gstz1 | -3337 |
SELENOAMINO ACID METABOLISM
915 | |
---|---|
set | SELENOAMINO ACID METABOLISM |
setSize | 110 |
pANOVA | 1.46e-20 |
s.dist | -0.513 |
p.adjustANOVA | 2.46e-18 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Rps17 | -7426 |
Rps8 | -7421 |
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Rps17 | -7426 |
Rps8 | -7421 |
Rpl31 | -7250 |
Rplp1 | -7160 |
Rpl26 | -7071 |
Rps11 | -7053 |
Rps27a | -7027 |
Rpl24 | -7004 |
Inmt | -6902 |
Rpl10a | -6880 |
Rpl36 | -6858 |
Rpl14 | -6787 |
Rps26 | -6585 |
Rpl29 | -6490 |
Rps7 | -6355 |
Rplp2 | -6350 |
Rps19 | -6333 |
Rpl22l1 | -6218 |
Rpl34 | -6199 |
Uba52 | -6187 |
Rpl32 | -6163 |
Rpl18 | -6160 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rpl28 | -5977 |
Rps16 | -5972 |
Rpl22 | -5905 |
Fau | -5890 |
Rps6 | -5794 |
Rpl19 | -5752 |
Rpl15 | -5718 |
Rps15a | -5694 |
Rpl11 | -5571 |
Rps24 | -5471 |
Rpl12 | -5252 |
Rps18 | -5182 |
Rpl13 | -5180 |
Rpl27a | -5162 |
Rpl4 | -5136 |
Rps5 | -4990 |
Rps9 | -4981 |
Gsr | -4921 |
Rpl8 | -4888 |
Rps4x | -4846 |
Rpl3 | -4835 |
Rpl18a | -4813 |
Mars1 | -4676 |
Rps3a1 | -4631 |
Rpl6 | -4589 |
Rpl7 | -4400 |
Rps13 | -4263 |
Rpl27 | -4253 |
Rps27l | -4091 |
Rps2 | -4058 |
Rpl13a | -4006 |
Rpl17 | -3909 |
Rps14 | -3804 |
Aimp1 | -3686 |
Ahcy | -3269 |
Rpsa | -3236 |
Rpl7a | -2903 |
Rpl9 | -2750 |
Rps10 | -2748 |
Eefsec | -2523 |
Gnmt | -2343 |
Eef1e1 | -2291 |
Hnmt | -1900 |
Rps3 | -1626 |
Sepsecs | -1591 |
Aimp2 | -1550 |
Rpl3l | -1143 |
Eprs | -776 |
Rpl5 | 46 |
Secisbp2 | 416 |
Sars | 764 |
Papss2 | 955 |
Rplp0 | 1020 |
Papss1 | 1201 |
Txnrd1 | 1562 |
Rpl10 | 1911 |
Lars | 1955 |
Pstk | 2258 |
Rars | 3683 |
Kars | 3789 |
Dars | 5055 |
Qars | 5563 |
Cbs | 6322 |
Iars | 6415 |
Cth | 6451 |
Scly | 7332 |
Sephs2 | 7463 |
EUKARYOTIC TRANSLATION INITIATION
307 | |
---|---|
set | EUKARYOTIC TRANSLATION INITIATION |
setSize | 115 |
pANOVA | 1.57e-19 |
s.dist | -0.488 |
p.adjustANOVA | 2.06e-17 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Eif3a | -8016 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Eif5b | -7783 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Eif3a | -8016 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Eif5b | -7783 |
Rps23 | -7780 |
Rpl36al | -7752 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Rps17 | -7426 |
Rps8 | -7421 |
Rpl31 | -7250 |
Rplp1 | -7160 |
Rpl26 | -7071 |
Rps11 | -7053 |
Rps27a | -7027 |
Rpl24 | -7004 |
Rpl10a | -6880 |
Rpl36 | -6858 |
Rpl14 | -6787 |
Eif4a1 | -6776 |
Rps26 | -6585 |
Rpl29 | -6490 |
Rps7 | -6355 |
Rplp2 | -6350 |
Rps19 | -6333 |
Eif2s2 | -6239 |
Rpl22l1 | -6218 |
Rpl34 | -6199 |
Uba52 | -6187 |
Rpl32 | -6163 |
Rpl18 | -6160 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rpl28 | -5977 |
Rps16 | -5972 |
Rpl22 | -5905 |
Fau | -5890 |
Rps6 | -5794 |
Rpl19 | -5752 |
Rpl15 | -5718 |
Rps15a | -5694 |
Rpl11 | -5571 |
Rps24 | -5471 |
Rpl12 | -5252 |
Rps18 | -5182 |
Rpl13 | -5180 |
Rpl27a | -5162 |
Rpl4 | -5136 |
Rps5 | -4990 |
Rps9 | -4981 |
Rpl8 | -4888 |
Rps4x | -4846 |
Rpl3 | -4835 |
Rpl18a | -4813 |
Rps3a1 | -4631 |
Rpl6 | -4589 |
Rpl7 | -4400 |
Rps13 | -4263 |
Rpl27 | -4253 |
Eif2b3 | -4092 |
Rps27l | -4091 |
Rps2 | -4058 |
Rpl13a | -4006 |
Rpl17 | -3909 |
Eif3j1 | -3873 |
Rps14 | -3804 |
Eif3g | -3606 |
Rpsa | -3236 |
Eif3k | -2953 |
Rpl7a | -2903 |
Rpl9 | -2750 |
Rps10 | -2748 |
Eif3e | -2360 |
Rps3 | -1626 |
Rpl3l | -1143 |
Eif3j2 | -684 |
Pabpc1 | -661 |
Eif3c | -650 |
Eif4ebp1 | -225 |
Rpl5 | 46 |
Eif3h | 427 |
Rplp0 | 1020 |
Eif3b | 1202 |
Eif3l | 1373 |
Eif2s3x | 1484 |
Eif3f | 1775 |
Eif3i | 1893 |
Rpl10 | 1911 |
Eif4e | 2249 |
Eif2b4 | 2377 |
Eif3m | 2474 |
Eif2s1 | 3113 |
Eif4g1 | 3132 |
Eif4b | 3480 |
Eif3d | 3617 |
Eif2b1 | 5454 |
Eif4h | 5491 |
Eif2b5 | 6573 |
Eif4a2 | 6904 |
Eif5 | 7801 |
Eif1ax | 7855 |
Eif2b2 | 8705 |
SEROTONIN RECEPTORS
927 | |
---|---|
set | SEROTONIN RECEPTORS |
setSize | 10 |
pANOVA | 0.00862 |
s.dist | 0.48 |
p.adjustANOVA | 0.0714 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Htr5a | 8755 |
Htr2a | 8433 |
Htr1f | 7705 |
Htr4 | 7296 |
Htr2c | 6329 |
Htr7 | 5082 |
Htr6 | 3581 |
Htr1b | 1500 |
Htr1a | -478 |
Htr1d | -2876 |
GeneID | Gene Rank |
---|---|
Htr5a | 8755 |
Htr2a | 8433 |
Htr1f | 7705 |
Htr4 | 7296 |
Htr2c | 6329 |
Htr7 | 5082 |
Htr6 | 3581 |
Htr1b | 1500 |
Htr1a | -478 |
Htr1d | -2876 |
ASPARTATE AND ASPARAGINE METABOLISM
74 | |
---|---|
set | ASPARTATE AND ASPARAGINE METABOLISM |
setSize | 11 |
pANOVA | 0.00619 |
s.dist | 0.477 |
p.adjustANOVA | 0.0575 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slc25a13 | 8974 |
Folh1 | 8959 |
Slc25a12 | 6820 |
Nat8l | 6436 |
Got2 | 6181 |
Got1 | 5307 |
Gadl1 | 5160 |
Asns | 3915 |
Aspa | 1180 |
Aspg | 1145 |
Naalad2 | -4506 |
GeneID | Gene Rank |
---|---|
Slc25a13 | 8974 |
Folh1 | 8959 |
Slc25a12 | 6820 |
Nat8l | 6436 |
Got2 | 6181 |
Got1 | 5307 |
Gadl1 | 5160 |
Asns | 3915 |
Aspa | 1180 |
Aspg | 1145 |
Naalad2 | -4506 |
LYSOSPHINGOLIPID AND LPA RECEPTORS
524 | |
---|---|
set | LYSOSPHINGOLIPID AND LPA RECEPTORS |
setSize | 13 |
pANOVA | 0.00316 |
s.dist | -0.473 |
p.adjustANOVA | 0.0352 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Plppr1 | -7743 |
S1pr2 | -7701 |
Lpar2 | -6582 |
Plppr3 | -6176 |
S1pr4 | -6154 |
S1pr3 | -5550 |
Plppr5 | -5179 |
S1pr1 | -5091 |
Lpar1 | -3761 |
Plppr4 | -3509 |
Plppr2 | -2302 |
S1pr5 | 5007 |
Lpar3 | 6507 |
GeneID | Gene Rank |
---|---|
Plppr1 | -7743 |
S1pr2 | -7701 |
Lpar2 | -6582 |
Plppr3 | -6176 |
S1pr4 | -6154 |
S1pr3 | -5550 |
Plppr5 | -5179 |
S1pr1 | -5091 |
Lpar1 | -3761 |
Plppr4 | -3509 |
Plppr2 | -2302 |
S1pr5 | 5007 |
Lpar3 | 6507 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL
1042 | |
---|---|
set | SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL |
setSize | 13 |
pANOVA | 0.0041 |
s.dist | 0.46 |
p.adjustANOVA | 0.0429 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Inpp5j | 8635 |
Impa1 | 8633 |
Inpp4b | 7886 |
Impa2 | 7832 |
Mtmr7 | 7420 |
Inpp5b | 6351 |
Synj1 | 4694 |
Inpp5a | 4093 |
Mtmr9 | 2229 |
Inpp1 | 1389 |
Inpp4a | 464 |
Ocrl | -20 |
Isyna1 | -2938 |
GeneID | Gene Rank |
---|---|
Inpp5j | 8635 |
Impa1 | 8633 |
Inpp4b | 7886 |
Impa2 | 7832 |
Mtmr7 | 7420 |
Inpp5b | 6351 |
Synj1 | 4694 |
Inpp5a | 4093 |
Mtmr9 | 2229 |
Inpp1 | 1389 |
Inpp4a | 464 |
Ocrl | -20 |
Isyna1 | -2938 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION
162 | |
---|---|
set | CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION |
setSize | 11 |
pANOVA | 0.0107 |
s.dist | 0.444 |
p.adjustANOVA | 0.0786 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Itpr3 | 8936 |
Itpr1 | 7850 |
Ahcyl1 | 7319 |
Ppp3cb | 6940 |
Itpr2 | 5765 |
Ppp3r1 | 5746 |
Calm1 | 5178 |
Nfatc2 | 1843 |
Ppp3ca | 1306 |
Nfatc1 | -37 |
Nfatc3 | -4352 |
GeneID | Gene Rank |
---|---|
Itpr3 | 8936 |
Itpr1 | 7850 |
Ahcyl1 | 7319 |
Ppp3cb | 6940 |
Itpr2 | 5765 |
Ppp3r1 | 5746 |
Calm1 | 5178 |
Nfatc2 | 1843 |
Ppp3ca | 1306 |
Nfatc1 | -37 |
Nfatc3 | -4352 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS
793 | |
---|---|
set | REGULATION OF EXPRESSION OF SLITS AND ROBOS |
setSize | 165 |
pANOVA | 1.14e-22 |
s.dist | -0.442 |
p.adjustANOVA | 2.25e-20 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Upf3b | -8113 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Psmb8 | -7892 |
Rbm8a | -7850 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Elob | -7700 |
Rpl35 | -7645 |
Rpl36a | -7632 |
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Upf3b | -8113 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Rps21 | -7927 |
Psmb8 | -7892 |
Rbm8a | -7850 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Elob | -7700 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Rps17 | -7426 |
Rps8 | -7421 |
Sem1 | -7343 |
Rpl31 | -7250 |
Rplp1 | -7160 |
Rpl26 | -7071 |
Rps11 | -7053 |
Rps27a | -7027 |
Rpl24 | -7004 |
Magohb | -6884 |
Rpl10a | -6880 |
Rpl36 | -6858 |
Psmb9 | -6811 |
Rpl14 | -6787 |
Psme2 | -6785 |
Psme1 | -6705 |
Upf3a | -6603 |
Rps26 | -6585 |
Rpl29 | -6490 |
Rps7 | -6355 |
Rplp2 | -6350 |
Msi1 | -6334 |
Rps19 | -6333 |
Rpl22l1 | -6218 |
Ncbp2 | -6200 |
Rpl34 | -6199 |
Uba52 | -6187 |
Psma4 | -6171 |
Rpl32 | -6163 |
Rpl18 | -6160 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rpl28 | -5977 |
Rps16 | -5972 |
Rpl22 | -5905 |
Fau | -5890 |
Rps6 | -5794 |
Ubb | -5788 |
Rpl19 | -5752 |
Rpl15 | -5718 |
Rps15a | -5694 |
Ldb1 | -5677 |
Isl1 | -5637 |
Rpl11 | -5571 |
Rps24 | -5471 |
Eif4a3 | -5319 |
Rpl12 | -5252 |
Rps18 | -5182 |
Rpl13 | -5180 |
Rpl27a | -5162 |
Psmb10 | -5152 |
Magoh | -5137 |
Rpl4 | -5136 |
Rps5 | -4990 |
Rps9 | -4981 |
Rpl8 | -4888 |
Rps4x | -4846 |
Rpl3 | -4835 |
Rpl18a | -4813 |
Psmb6 | -4652 |
Rps3a1 | -4631 |
Rpl6 | -4589 |
Psma8 | -4476 |
Psma3 | -4401 |
Rpl7 | -4400 |
Upf2 | -4384 |
Lhx9 | -4354 |
Rbx1 | -4331 |
Rps13 | -4263 |
Rpl27 | -4253 |
Psmb4 | -4169 |
Rps27l | -4091 |
Rps2 | -4058 |
Rpl13a | -4006 |
Rpl17 | -3909 |
Rps14 | -3804 |
Psmc5 | -3574 |
Psmd13 | -3352 |
Psmd11 | -3256 |
Rpsa | -3236 |
Psmd7 | -3146 |
Psmc1 | -3062 |
Rpl7a | -2903 |
Rpl9 | -2750 |
Rps10 | -2748 |
Rnps1 | -2675 |
Lhx2 | -2612 |
Psmd9 | -2560 |
Col4a5 | -2478 |
Psmb1 | -2233 |
Psmc4 | -2148 |
Psmd3 | -1976 |
Psmc3 | -1856 |
Gspt2 | -1659 |
Rps3 | -1626 |
Ubc | -1603 |
Psmb7 | -1198 |
Rpl3l | -1143 |
Psmd12 | -1084 |
Psmd8 | -1009 |
Psmd4 | -969 |
Pabpc1 | -661 |
Psmb5 | -557 |
Robo3 | -169 |
Psmb3 | -84 |
Psmc2 | 16 |
Rpl5 | 46 |
Slit1 | 133 |
Eloc | 206 |
Zswim8 | 309 |
Casc3 | 400 |
Psma7 | 610 |
Etf1 | 798 |
Psmb2 | 889 |
Psma6 | 894 |
Rplp0 | 1020 |
Psmd10 | 1582 |
Psmd14 | 1588 |
Lhx4 | 1605 |
Psmd1 | 1846 |
Rpl10 | 1911 |
Psmd6 | 1924 |
Psma1 | 1971 |
Psma2 | 1978 |
Cul2 | 2148 |
Psma5 | 2437 |
Hoxa2 | 2555 |
Ncbp1 | 2649 |
Psmc6 | 2951 |
Eif4g1 | 3132 |
Slit2 | 3755 |
Lhx3 | 3993 |
Dag1 | 4358 |
Psme4 | 4502 |
Psmd2 | 4620 |
Robo1 | 6486 |
Psmf1 | 6964 |
Gspt1 | 6993 |
Psme3 | 7033 |
Usp33 | 7314 |
Robo2 | 7751 |
Psmd5 | 7993 |
BRANCHED CHAIN AMINO ACID CATABOLISM
105 | |
---|---|
set | BRANCHED CHAIN AMINO ACID CATABOLISM |
setSize | 21 |
pANOVA | 0.00048 |
s.dist | 0.44 |
p.adjustANOVA | 0.00873 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Aldh6a1 | 8794 |
Slc25a44 | 8203 |
Ppm1k | 8025 |
Bcat1 | 7988 |
Bckdk | 6956 |
Bckdhb | 6910 |
Dld | 6763 |
Dbt | 6310 |
Hsd17b10 | 5880 |
Echs1 | 5761 |
Acadsb | 5337 |
Bckdha | 5080 |
Hibadh | 4306 |
Auh | 3614 |
Mccc1 | 3231 |
Acat1 | 1915 |
Acad8 | 284 |
Ivd | -1246 |
Bcat2 | -1263 |
Hibch | -1534 |
GeneID | Gene Rank |
---|---|
Aldh6a1 | 8794 |
Slc25a44 | 8203 |
Ppm1k | 8025 |
Bcat1 | 7988 |
Bckdk | 6956 |
Bckdhb | 6910 |
Dld | 6763 |
Dbt | 6310 |
Hsd17b10 | 5880 |
Echs1 | 5761 |
Acadsb | 5337 |
Bckdha | 5080 |
Hibadh | 4306 |
Auh | 3614 |
Mccc1 | 3231 |
Acat1 | 1915 |
Acad8 | 284 |
Ivd | -1246 |
Bcat2 | -1263 |
Hibch | -1534 |
Mccc2 | -3376 |
FGFR2 ALTERNATIVE SPLICING
325 | |
---|---|
set | FGFR2 ALTERNATIVE SPLICING |
setSize | 25 |
pANOVA | 0.000165 |
s.dist | -0.435 |
p.adjustANOVA | 0.00367 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hnrnph1 | -7764 |
Polr2l | -7491 |
Hnrnpa1 | -7092 |
Polr2k | -6751 |
Hnrnpm | -6544 |
Gtf2f1 | -6432 |
Ncbp2 | -6200 |
Polr2f | -5888 |
Tia1 | -5491 |
Gtf2f2 | -5390 |
Tial1 | -5025 |
Polr2g | -4548 |
Ptbp1 | -4342 |
Fgfr2 | -4338 |
Polr2e | -4206 |
Polr2i | -4083 |
Polr2d | -3931 |
Polr2h | -1758 |
Polr2j | -1316 |
Polr2c | -1130 |
GeneID | Gene Rank |
---|---|
Hnrnph1 | -7764 |
Polr2l | -7491 |
Hnrnpa1 | -7092 |
Polr2k | -6751 |
Hnrnpm | -6544 |
Gtf2f1 | -6432 |
Ncbp2 | -6200 |
Polr2f | -5888 |
Tia1 | -5491 |
Gtf2f2 | -5390 |
Tial1 | -5025 |
Polr2g | -4548 |
Ptbp1 | -4342 |
Fgfr2 | -4338 |
Polr2e | -4206 |
Polr2i | -4083 |
Polr2d | -3931 |
Polr2h | -1758 |
Polr2j | -1316 |
Polr2c | -1130 |
Rbfox2 | 1521 |
Hnrnpf | 1903 |
Polr2a | 2530 |
Ncbp1 | 2649 |
Polr2b | 6541 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE
1048 | |
---|---|
set | SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE |
setSize | 16 |
pANOVA | 0.0026 |
s.dist | 0.435 |
p.adjustANOVA | 0.0308 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fig4 | 8626 |
Mtmr2 | 8484 |
Pik3c2a | 8120 |
Pik3c3 | 7990 |
Inpp4b | 7886 |
Pi4k2a | 7640 |
Vac14 | 7547 |
Mtmr4 | 4004 |
Mtmr12 | 2522 |
Inpp5f | 2226 |
Pik3r4 | 1359 |
Pikfyve | 957 |
Inpp4a | 464 |
Mtmr10 | 463 |
Mtm1 | -162 |
Pi4k2b | -1848 |
GeneID | Gene Rank |
---|---|
Fig4 | 8626 |
Mtmr2 | 8484 |
Pik3c2a | 8120 |
Pik3c3 | 7990 |
Inpp4b | 7886 |
Pi4k2a | 7640 |
Vac14 | 7547 |
Mtmr4 | 4004 |
Mtmr12 | 2522 |
Inpp5f | 2226 |
Pik3r4 | 1359 |
Pikfyve | 957 |
Inpp4a | 464 |
Mtmr10 | 463 |
Mtm1 | -162 |
Pi4k2b | -1848 |
REDUCTION OF CYTOSOLIC CA LEVELS
786 | |
---|---|
set | REDUCTION OF CYTOSOLIC CA LEVELS |
setSize | 11 |
pANOVA | 0.0132 |
s.dist | 0.432 |
p.adjustANOVA | 0.0885 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Atp2a2 | 6793 |
Slc8a2 | 6374 |
Atp2b3 | 6023 |
Sri | 5522 |
Calm1 | 5178 |
Atp2b2 | 4527 |
Atp2b4 | 3902 |
Slc8a3 | 3321 |
Atp2a3 | 2206 |
Slc8a1 | 1827 |
Atp2b1 | -390 |
GeneID | Gene Rank |
---|---|
Atp2a2 | 6793 |
Slc8a2 | 6374 |
Atp2b3 | 6023 |
Sri | 5522 |
Calm1 | 5178 |
Atp2b2 | 4527 |
Atp2b4 | 3902 |
Slc8a3 | 3321 |
Atp2a3 | 2206 |
Slc8a1 | 1827 |
Atp2b1 | -390 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION
398 | |
---|---|
set | GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION |
setSize | 12 |
pANOVA | 0.00965 |
s.dist | 0.431 |
p.adjustANOVA | 0.076 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mapk1 | 8781 |
Uso1 | 8158 |
Cdk1 | 7663 |
Blzf1 | 7140 |
Gorasp2 | 5518 |
Rab2a | 4325 |
Rab1b | 4161 |
Golga2 | 2840 |
Gorasp1 | 1183 |
Mapk3 | 662 |
Rab1a | -136 |
Plk1 | -918 |
GeneID | Gene Rank |
---|---|
Mapk1 | 8781 |
Uso1 | 8158 |
Cdk1 | 7663 |
Blzf1 | 7140 |
Gorasp2 | 5518 |
Rab2a | 4325 |
Rab1b | 4161 |
Golga2 | 2840 |
Gorasp1 | 1183 |
Mapk3 | 662 |
Rab1a | -136 |
Plk1 | -918 |
RHOBTB2 GTPASE CYCLE
863 | |
---|---|
set | RHOBTB2 GTPASE CYCLE |
setSize | 23 |
pANOVA | 0.000381 |
s.dist | -0.428 |
p.adjustANOVA | 0.00738 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hsp90ab1 | -7101 |
Hsp90aa1 | -6761 |
Rbmx | -6579 |
Cct7 | -6510 |
Rhobtb2 | -6464 |
Phip | -6046 |
Ddx39b | -5634 |
Stk38 | -5404 |
Cdc37 | -5257 |
Actn1 | -4407 |
Cct6a | -3374 |
Hnrnpc | -3371 |
Cct2 | -3189 |
Actg1 | -3112 |
Srrm1 | -2908 |
Dbn1 | -2870 |
Twf1 | -1403 |
Cul3 | -700 |
Tra2b | -526 |
Tmod3 | -256 |
GeneID | Gene Rank |
---|---|
Hsp90ab1 | -7101 |
Hsp90aa1 | -6761 |
Rbmx | -6579 |
Cct7 | -6510 |
Rhobtb2 | -6464 |
Phip | -6046 |
Ddx39b | -5634 |
Stk38 | -5404 |
Cdc37 | -5257 |
Actn1 | -4407 |
Cct6a | -3374 |
Hnrnpc | -3371 |
Cct2 | -3189 |
Actg1 | -3112 |
Srrm1 | -2908 |
Dbn1 | -2870 |
Twf1 | -1403 |
Cul3 | -700 |
Tra2b | -526 |
Tmod3 | -256 |
Msi2 | -106 |
Txnl1 | 1406 |
Myo6 | 4219 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER
976 | |
---|---|
set | SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER |
setSize | 15 |
pANOVA | 0.00457 |
s.dist | -0.423 |
p.adjustANOVA | 0.0462 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dll1 | -8061 |
Rps27a | -7027 |
Adam17 | -6639 |
Uba52 | -6187 |
Jag1 | -5926 |
Ubb | -5788 |
Jag2 | -5784 |
Mib2 | -2687 |
Neurl1b | -2633 |
Dll4 | -2516 |
Ubc | -1603 |
Notch1 | -183 |
Mib1 | 240 |
Adam10 | 1875 |
Neurl1a | 3752 |
GeneID | Gene Rank |
---|---|
Dll1 | -8061 |
Rps27a | -7027 |
Adam17 | -6639 |
Uba52 | -6187 |
Jag1 | -5926 |
Ubb | -5788 |
Jag2 | -5784 |
Mib2 | -2687 |
Neurl1b | -2633 |
Dll4 | -2516 |
Ubc | -1603 |
Notch1 | -183 |
Mib1 | 240 |
Adam10 | 1875 |
Neurl1a | 3752 |
CITRIC ACID CYCLE TCA CYCLE
155 | |
---|---|
set | CITRIC ACID CYCLE TCA CYCLE |
setSize | 22 |
pANOVA | 0.000719 |
s.dist | 0.417 |
p.adjustANOVA | 0.0116 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Aco2 | 8593 |
Suclg2 | 7625 |
Idh3a | 7550 |
Idh3g | 7000 |
Dld | 6763 |
Sdhd | 6426 |
Sucla2 | 6383 |
Ogdh | 6275 |
Dlst | 6258 |
Cs | 6241 |
Me2 | 5731 |
Me3 | 5525 |
Idh3b | 3887 |
Sdha | 3177 |
Sdhc | 2990 |
Sdhb | 2836 |
Nnt | 2202 |
Mdh2 | 1857 |
Fahd1 | 333 |
Suclg1 | -2096 |
GeneID | Gene Rank |
---|---|
Aco2 | 8593 |
Suclg2 | 7625 |
Idh3a | 7550 |
Idh3g | 7000 |
Dld | 6763 |
Sdhd | 6426 |
Sucla2 | 6383 |
Ogdh | 6275 |
Dlst | 6258 |
Cs | 6241 |
Me2 | 5731 |
Me3 | 5525 |
Idh3b | 3887 |
Sdha | 3177 |
Sdhc | 2990 |
Sdhb | 2836 |
Nnt | 2202 |
Mdh2 | 1857 |
Fahd1 | 333 |
Suclg1 | -2096 |
Fh1 | -3436 |
Idh2 | -4479 |
INFLUENZA INFECTION
446 | |
---|---|
set | INFLUENZA INFECTION |
setSize | 146 |
pANOVA | 1.05e-17 |
s.dist | -0.411 |
p.adjustANOVA | 1.24e-15 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Calr | -7980 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Isg15 | -7748 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Polr2l | -7491 |
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Rps27 | -8128 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Calr | -7980 |
Rpl37a | -7975 |
Rps21 | -7927 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Isg15 | -7748 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Rpl23a | -7500 |
Polr2l | -7491 |
Rpl35a | -7461 |
Rps17 | -7426 |
Rps8 | -7421 |
Rpl31 | -7250 |
Rplp1 | -7160 |
Hspa1a | -7112 |
Rpl26 | -7071 |
Rps11 | -7053 |
Rps27a | -7027 |
Rpl24 | -7004 |
Dnajc3 | -6919 |
Rpl10a | -6880 |
Rpl36 | -6858 |
Rpl14 | -6787 |
Hsp90aa1 | -6761 |
Polr2k | -6751 |
Rps26 | -6585 |
Rpl29 | -6490 |
Gtf2f1 | -6432 |
Rps7 | -6355 |
Rplp2 | -6350 |
Rps19 | -6333 |
Rpl22l1 | -6218 |
Rpl34 | -6199 |
Uba52 | -6187 |
Rpl32 | -6163 |
Rpl18 | -6160 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rpl28 | -5977 |
Rps16 | -5972 |
Rpl22 | -5905 |
Fau | -5890 |
Polr2f | -5888 |
Nup37 | -5823 |
Rps6 | -5794 |
Rpl19 | -5752 |
Rpl15 | -5718 |
Rps15a | -5694 |
Rpl11 | -5571 |
Rps24 | -5471 |
Gtf2f2 | -5390 |
Cpsf4 | -5340 |
Rpl12 | -5252 |
Rps18 | -5182 |
Rpl13 | -5180 |
Rpl27a | -5162 |
Rpl4 | -5136 |
Rps5 | -4990 |
Rps9 | -4981 |
Rpl8 | -4888 |
Rps4x | -4846 |
Rpl3 | -4835 |
Rpl18a | -4813 |
Rps3a1 | -4631 |
Rpl6 | -4589 |
Polr2g | -4548 |
Pabpn1 | -4418 |
Rpl7 | -4400 |
Rps13 | -4263 |
Rpl27 | -4253 |
Polr2e | -4206 |
Rps27l | -4091 |
Polr2i | -4083 |
Rps2 | -4058 |
Rpl13a | -4006 |
Polr2d | -3931 |
Rpl17 | -3909 |
Rps14 | -3804 |
Rpsa | -3236 |
Kpna2 | -3130 |
Tpr | -3104 |
Nupl2 | -3085 |
Nup214 | -2905 |
Rpl7a | -2903 |
Rpl9 | -2750 |
Rps10 | -2748 |
Ran | -2597 |
Eif2ak2 | -2453 |
Nup43 | -2007 |
Nup93 | -1936 |
Nup88 | -1809 |
Nup35 | -1805 |
Polr2h | -1758 |
Xpo1 | -1739 |
Rps3 | -1626 |
Polr2j | -1316 |
Rpl3l | -1143 |
Polr2c | -1130 |
Nup54 | -916 |
Tgfb1 | -846 |
Nup107 | -429 |
Rae1 | -317 |
Aaas | -92 |
Rpl5 | 46 |
Nup160 | 201 |
Rplp0 | 1020 |
Canx | 1783 |
Rpl10 | 1911 |
Clta | 1933 |
Nup98 | 1945 |
Sec13 | 2455 |
Polr2a | 2530 |
Nup62 | 2773 |
Kpnb1 | 3448 |
Nup133 | 3501 |
Nup85 | 3707 |
Nup205 | 3866 |
Ipo5 | 4070 |
Kpna1 | 4396 |
Nup155 | 4730 |
Nup153 | 4823 |
Nup50 | 5555 |
Pom121 | 5939 |
Parp1 | 5986 |
Nup210 | 6217 |
Polr2b | 6541 |
Nup188 | 7696 |
Seh1l | 7799 |
Cltc | 7910 |
Ndc1 | 8330 |
Ranbp2 | 8335 |
Kpna4 | 8786 |
Grsf1 | 8850 |
Kpna3 | 8953 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES
83 | |
---|---|
set | ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES |
setSize | 10 |
pANOVA | 0.0254 |
s.dist | -0.408 |
p.adjustANOVA | 0.134 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hspa5 | -8172 |
Ddit3 | -8171 |
Hsp90b1 | -8155 |
Xbp1 | -8038 |
Calr | -7980 |
Atf4 | -3007 |
Nfyb | -2777 |
Nfya | 954 |
Nfyc | 5233 |
Atf6 | 8605 |
GeneID | Gene Rank |
---|---|
Hspa5 | -8172 |
Ddit3 | -8171 |
Hsp90b1 | -8155 |
Xbp1 | -8038 |
Calr | -7980 |
Atf4 | -3007 |
Nfyb | -2777 |
Nfya | 954 |
Nfyc | 5233 |
Atf6 | 8605 |
RHO GTPASES ACTIVATE NADPH OXIDASES
854 | |
---|---|
set | RHO GTPASES ACTIVATE NADPH OXIDASES |
setSize | 21 |
pANOVA | 0.00121 |
s.dist | 0.408 |
p.adjustANOVA | 0.0179 |
Top enriched genes
GeneID | Gene Rank |
---|---|
S100a8 | 9016 |
S100a9 | 9013 |
Ncf1 | 8854 |
Mapk1 | 8781 |
Prkcd | 8220 |
Rac2 | 7994 |
Pik3c3 | 7990 |
Cybb | 7023 |
Ncf4 | 6795 |
Noxo1 | 5728 |
Prkcb | 4120 |
Pin1 | 2408 |
Mapk14 | 1527 |
Rac1 | 1495 |
Prkcz | 1477 |
Pik3r4 | 1359 |
Prkca | 847 |
Mapk3 | 662 |
Mapk11 | -1982 |
Cyba | -3028 |
GeneID | Gene Rank |
---|---|
S100a8 | 9016 |
S100a9 | 9013 |
Ncf1 | 8854 |
Mapk1 | 8781 |
Prkcd | 8220 |
Rac2 | 7994 |
Pik3c3 | 7990 |
Cybb | 7023 |
Ncf4 | 6795 |
Noxo1 | 5728 |
Prkcb | 4120 |
Pin1 | 2408 |
Mapk14 | 1527 |
Rac1 | 1495 |
Prkcz | 1477 |
Pik3r4 | 1359 |
Prkca | 847 |
Mapk3 | 662 |
Mapk11 | -1982 |
Cyba | -3028 |
Ncf2 | -6209 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB
112 | |
---|---|
set | CAMK IV MEDIATED PHOSPHORYLATION OF CREB |
setSize | 10 |
pANOVA | 0.0259 |
s.dist | 0.407 |
p.adjustANOVA | 0.134 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Camk4 | 8156 |
Camkk1 | 8079 |
Camk2g | 7554 |
Camkk2 | 6273 |
Calm1 | 5178 |
Camk2d | 3466 |
Camk2a | 2757 |
Creb1 | 1050 |
Camk2b | -357 |
Kpna2 | -3130 |
GeneID | Gene Rank |
---|---|
Camk4 | 8156 |
Camkk1 | 8079 |
Camk2g | 7554 |
Camkk2 | 6273 |
Calm1 | 5178 |
Camk2d | 3466 |
Camk2a | 2757 |
Creb1 | 1050 |
Camk2b | -357 |
Kpna2 | -3130 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES
757 | |
---|---|
set | PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES |
setSize | 13 |
pANOVA | 0.0115 |
s.dist | 0.405 |
p.adjustANOVA | 0.0814 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Elmo2 | 8040 |
Crk | 7897 |
Bcar1 | 7386 |
Elmo1 | 6602 |
Kras | 6077 |
Dock1 | 5623 |
Rasa1 | 4617 |
Arhgap35 | 4380 |
Nras | 4195 |
Rhoa | 3577 |
Rac1 | 1495 |
Pxn | -3107 |
Hras | -6302 |
GeneID | Gene Rank |
---|---|
Elmo2 | 8040 |
Crk | 7897 |
Bcar1 | 7386 |
Elmo1 | 6602 |
Kras | 6077 |
Dock1 | 5623 |
Rasa1 | 4617 |
Arhgap35 | 4380 |
Nras | 4195 |
Rhoa | 3577 |
Rac1 | 1495 |
Pxn | -3107 |
Hras | -6302 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
29 | |
---|---|
set | ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S |
setSize | 59 |
pANOVA | 1.04e-07 |
s.dist | -0.4 |
p.adjustANOVA | 5.36e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rps27 | -8128 |
Eif3a | -8016 |
Rps21 | -7927 |
Rps20 | -7805 |
Rps23 | -7780 |
Rps17 | -7426 |
Rps8 | -7421 |
Rps11 | -7053 |
Rps27a | -7027 |
Eif4a1 | -6776 |
Rps26 | -6585 |
Rps7 | -6355 |
Rps19 | -6333 |
Eif2s2 | -6239 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rps16 | -5972 |
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rps27 | -8128 |
Eif3a | -8016 |
Rps21 | -7927 |
Rps20 | -7805 |
Rps23 | -7780 |
Rps17 | -7426 |
Rps8 | -7421 |
Rps11 | -7053 |
Rps27a | -7027 |
Eif4a1 | -6776 |
Rps26 | -6585 |
Rps7 | -6355 |
Rps19 | -6333 |
Eif2s2 | -6239 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rps16 | -5972 |
Fau | -5890 |
Rps6 | -5794 |
Rps15a | -5694 |
Rps24 | -5471 |
Rps18 | -5182 |
Rps5 | -4990 |
Rps9 | -4981 |
Rps4x | -4846 |
Rps3a1 | -4631 |
Rps13 | -4263 |
Rps27l | -4091 |
Rps2 | -4058 |
Eif3j1 | -3873 |
Rps14 | -3804 |
Eif3g | -3606 |
Rpsa | -3236 |
Eif3k | -2953 |
Rps10 | -2748 |
Eif3e | -2360 |
Rps3 | -1626 |
Eif3j2 | -684 |
Pabpc1 | -661 |
Eif3c | -650 |
Eif4ebp1 | -225 |
Eif3h | 427 |
Eif3b | 1202 |
Eif3l | 1373 |
Eif2s3x | 1484 |
Eif3f | 1775 |
Eif3i | 1893 |
Eif4e | 2249 |
Eif3m | 2474 |
Eif2s1 | 3113 |
Eif4g1 | 3132 |
Eif4b | 3480 |
Eif3d | 3617 |
Eif4h | 5491 |
Eif4a2 | 6904 |
Eif1ax | 7855 |
HSF1 ACTIVATION
433 | |
---|---|
set | HSF1 ACTIVATION |
setSize | 27 |
pANOVA | 0.000354 |
s.dist | -0.397 |
p.adjustANOVA | 0.00696 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Serpinh1 | -8229 |
Hspb1 | -7873 |
Hspa1b | -7483 |
Hsph1 | -7270 |
Fkbp4 | -7157 |
Hspa1a | -7112 |
Hsp90ab1 | -7101 |
Hsf1 | -6826 |
Hsp90aa1 | -6761 |
Ptges3 | -6622 |
Dnajb1 | -6438 |
Ubb | -5788 |
Vcp | -5485 |
Hsbp1 | -4782 |
Dnajb6 | -4079 |
Mrpl18 | -3308 |
Hdac6 | -2027 |
Rln1 | -2003 |
Hspb2 | -1870 |
Eef1a1 | -1720 |
GeneID | Gene Rank |
---|---|
Serpinh1 | -8229 |
Hspb1 | -7873 |
Hspa1b | -7483 |
Hsph1 | -7270 |
Fkbp4 | -7157 |
Hspa1a | -7112 |
Hsp90ab1 | -7101 |
Hsf1 | -6826 |
Hsp90aa1 | -6761 |
Ptges3 | -6622 |
Dnajb1 | -6438 |
Ubb | -5788 |
Vcp | -5485 |
Hsbp1 | -4782 |
Dnajb6 | -4079 |
Mrpl18 | -3308 |
Hdac6 | -2027 |
Rln1 | -2003 |
Hspb2 | -1870 |
Eef1a1 | -1720 |
Ywhae | -928 |
Col4a6 | 2570 |
Dedd2 | 3130 |
Tnfrsf21 | 4245 |
Rpa2 | 4431 |
Rpa1 | 6660 |
Rpa3 | 7387 |
GLYCOSPHINGOLIPID METABOLISM
395 | |
---|---|
set | GLYCOSPHINGOLIPID METABOLISM |
setSize | 37 |
pANOVA | 3.18e-05 |
s.dist | 0.395 |
p.adjustANOVA | 0.000816 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Neu4 | 8948 |
Arsk | 8683 |
Gba | 8619 |
Neu3 | 8468 |
Cptp | 8127 |
Esyt1 | 7918 |
Galc | 7905 |
Esyt2 | 7822 |
Gla | 7515 |
Cerk | 7378 |
B4galnt1 | 7352 |
Arsb | 7176 |
Psap | 7077 |
Asah2 | 7051 |
Neu1 | 6836 |
Asah1 | 6624 |
B3galnt1 | 5729 |
Gba2 | 5576 |
Arsg | 5409 |
Ctsa | 4924 |
GeneID | Gene Rank |
---|---|
Neu4 | 8948 |
Arsk | 8683 |
Gba | 8619 |
Neu3 | 8468 |
Cptp | 8127 |
Esyt1 | 7918 |
Galc | 7905 |
Esyt2 | 7822 |
Gla | 7515 |
Cerk | 7378 |
B4galnt1 | 7352 |
Arsb | 7176 |
Psap | 7077 |
Asah2 | 7051 |
Neu1 | 6836 |
Asah1 | 6624 |
B3galnt1 | 5729 |
Gba2 | 5576 |
Arsg | 5409 |
Ctsa | 4924 |
Smpd3 | 4718 |
Glb1 | 4008 |
Ugcg | 3912 |
Gm2a | 3507 |
Gltp | 2546 |
Neu2 | 1517 |
Smpd1 | 1299 |
Glb1l | 651 |
Smpd2 | -54 |
Arsa | -315 |
Sumf1 | -348 |
Esyt3 | -2586 |
Smpd4 | -2730 |
Hexb | -2797 |
Ugt8a | -4848 |
Hexa | -5919 |
Sumf2 | -7239 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS
942 | |
---|---|
set | SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS |
setSize | 15 |
pANOVA | 0.00815 |
s.dist | 0.395 |
p.adjustANOVA | 0.0687 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ppp2r1b | 8351 |
Csnk1a1 | 7934 |
Ctnnb1 | 6376 |
Amer1 | 5741 |
Axin1 | 5591 |
Ppp2r5b | 5022 |
Ppp2r5e | 4146 |
Ppp2r1a | 3759 |
Gsk3b | 3069 |
Ppp2r5c | 2264 |
Ppp2cb | 2047 |
Apc | 1731 |
Ppp2ca | 1295 |
Ppp2r5a | 1161 |
Ppp2r5d | -1563 |
GeneID | Gene Rank |
---|---|
Ppp2r1b | 8351 |
Csnk1a1 | 7934 |
Ctnnb1 | 6376 |
Amer1 | 5741 |
Axin1 | 5591 |
Ppp2r5b | 5022 |
Ppp2r5e | 4146 |
Ppp2r1a | 3759 |
Gsk3b | 3069 |
Ppp2r5c | 2264 |
Ppp2cb | 2047 |
Apc | 1731 |
Ppp2ca | 1295 |
Ppp2r5a | 1161 |
Ppp2r5d | -1563 |
COMPLEX I BIOGENESIS
172 | |
---|---|
set | COMPLEX I BIOGENESIS |
setSize | 56 |
pANOVA | 4.45e-07 |
s.dist | -0.39 |
p.adjustANOVA | 1.94e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ndufa1 | -8060 |
Ndufa6 | -7988 |
Ndufa5 | -7932 |
mt-Nd3 | -7789 |
Ndufv3 | -7598 |
Ndufb1 | -7589 |
mt-Nd6 | -7554 |
Ndufa3 | -7547 |
Ndufb3 | -7138 |
Ndufs6 | -7098 |
Ndufa2 | -7083 |
Ndufb11 | -6893 |
Ndufs5 | -6865 |
Ndufa13 | -6783 |
Ndufc1 | -6652 |
Ndufa12 | -6407 |
Ndufb10 | -6167 |
Ndufaf3 | -6115 |
Ndufb7 | -6023 |
Tmem126b | -5436 |
GeneID | Gene Rank |
---|---|
Ndufa1 | -8060 |
Ndufa6 | -7988 |
Ndufa5 | -7932 |
mt-Nd3 | -7789 |
Ndufv3 | -7598 |
Ndufb1 | -7589 |
mt-Nd6 | -7554 |
Ndufa3 | -7547 |
Ndufb3 | -7138 |
Ndufs6 | -7098 |
Ndufa2 | -7083 |
Ndufb11 | -6893 |
Ndufs5 | -6865 |
Ndufa13 | -6783 |
Ndufc1 | -6652 |
Ndufa12 | -6407 |
Ndufb10 | -6167 |
Ndufaf3 | -6115 |
Ndufb7 | -6023 |
Tmem126b | -5436 |
Ndufb2 | -5077 |
Ndufab1 | -4718 |
mt-Nd1 | -4601 |
Ndufc2 | -4423 |
Ndufb9 | -4375 |
Ndufb5 | -3445 |
Tmem186 | -2778 |
Ndufv2 | -2738 |
Ndufs4 | -2542 |
Ndufaf6 | -2510 |
Ndufa8 | -2269 |
Ndufaf4 | -2253 |
Ndufaf2 | -2132 |
mt-Nd4 | -2025 |
mt-Nd2 | -1785 |
Ndufaf7 | -1774 |
Ndufs8 | -1647 |
Ndufs3 | -1519 |
Ndufb6 | -1479 |
Ndufb4 | -1400 |
Ndufa7 | -772 |
Ndufa11 | -649 |
Ndufaf1 | -430 |
Ndufb8 | -354 |
Ndufs2 | -268 |
Ndufaf5 | 35 |
Timmdc1 | 104 |
Ndufv1 | 134 |
Ndufs7 | 383 |
Ndufa10 | 487 |
Nubpl | 2273 |
Ndufa9 | 4322 |
Ecsit | 4658 |
mt-Nd5 | 5254 |
Ndufs1 | 6700 |
Acad9 | 7136 |
RHOBTB3 ATPASE CYCLE
864 | |
---|---|
set | RHOBTB3 ATPASE CYCLE |
setSize | 10 |
pANOVA | 0.0337 |
s.dist | 0.388 |
p.adjustANOVA | 0.149 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Plin3 | 7471 |
Rhobtb3 | 7067 |
Rab9b | 6638 |
Ccne1 | 6166 |
Vhl | 5925 |
Htr7 | 5082 |
Lrrc41 | 2620 |
Hgs | 1686 |
Cul3 | -700 |
Rab9 | -4571 |
GeneID | Gene Rank |
---|---|
Plin3 | 7471 |
Rhobtb3 | 7067 |
Rab9b | 6638 |
Ccne1 | 6166 |
Vhl | 5925 |
Htr7 | 5082 |
Lrrc41 | 2620 |
Hgs | 1686 |
Cul3 | -700 |
Rab9 | -4571 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE
224 | |
---|---|
set | DEGRADATION OF CYSTEINE AND HOMOCYSTEINE |
setSize | 13 |
pANOVA | 0.0157 |
s.dist | 0.387 |
p.adjustANOVA | 0.0989 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Suox | 7686 |
Cth | 6451 |
Slc25a10 | 6416 |
Csad | 6215 |
Got2 | 6181 |
Ado | 5838 |
Gadl1 | 5160 |
Mpst | 3414 |
Ethe1 | 2960 |
Sqor | 2279 |
Cdo1 | 673 |
Txn2 | -417 |
Tst | -4388 |
GeneID | Gene Rank |
---|---|
Suox | 7686 |
Cth | 6451 |
Slc25a10 | 6416 |
Csad | 6215 |
Got2 | 6181 |
Ado | 5838 |
Gadl1 | 5160 |
Mpst | 3414 |
Ethe1 | 2960 |
Sqor | 2279 |
Cdo1 | 673 |
Txn2 | -417 |
Tst | -4388 |
BETA CATENIN PHOSPHORYLATION CASCADE
95 | |
---|---|
set | BETA CATENIN PHOSPHORYLATION CASCADE |
setSize | 16 |
pANOVA | 0.00751 |
s.dist | 0.386 |
p.adjustANOVA | 0.0652 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ppp2r1b | 8351 |
Csnk1a1 | 7934 |
Ctnnb1 | 6376 |
Amer1 | 5741 |
Axin1 | 5591 |
Ppp2r5b | 5022 |
Ppp2r5e | 4146 |
Ppp2r1a | 3759 |
Gsk3b | 3069 |
Frat2 | 2606 |
Ppp2r5c | 2264 |
Ppp2cb | 2047 |
Apc | 1731 |
Ppp2ca | 1295 |
Ppp2r5a | 1161 |
Ppp2r5d | -1563 |
GeneID | Gene Rank |
---|---|
Ppp2r1b | 8351 |
Csnk1a1 | 7934 |
Ctnnb1 | 6376 |
Amer1 | 5741 |
Axin1 | 5591 |
Ppp2r5b | 5022 |
Ppp2r5e | 4146 |
Ppp2r1a | 3759 |
Gsk3b | 3069 |
Frat2 | 2606 |
Ppp2r5c | 2264 |
Ppp2cb | 2047 |
Apc | 1731 |
Ppp2ca | 1295 |
Ppp2r5a | 1161 |
Ppp2r5d | -1563 |
G PROTEIN ACTIVATION
357 | |
---|---|
set | G PROTEIN ACTIVATION |
setSize | 23 |
pANOVA | 0.00139 |
s.dist | -0.385 |
p.adjustANOVA | 0.0202 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pomc | -8121 |
Gng11 | -7971 |
Gng5 | -7495 |
Gnaq | -6362 |
Gng13 | -6025 |
Pdyn | -5936 |
Gna11 | -5869 |
Gna15 | -5309 |
Gnb2 | -5029 |
Gnb3 | -4857 |
Gng3 | -4751 |
Gngt2 | -3900 |
Gng2 | -3829 |
Gng4 | -3774 |
Gna14 | -3437 |
Gng10 | -2501 |
Gnb4 | -1920 |
Oprm1 | -780 |
Gnb1 | -65 |
Gng8 | 1475 |
GeneID | Gene Rank |
---|---|
Pomc | -8121 |
Gng11 | -7971 |
Gng5 | -7495 |
Gnaq | -6362 |
Gng13 | -6025 |
Pdyn | -5936 |
Gna11 | -5869 |
Gna15 | -5309 |
Gnb2 | -5029 |
Gnb3 | -4857 |
Gng3 | -4751 |
Gngt2 | -3900 |
Gng2 | -3829 |
Gng4 | -3774 |
Gna14 | -3437 |
Gng10 | -2501 |
Gnb4 | -1920 |
Oprm1 | -780 |
Gnb1 | -65 |
Gng8 | 1475 |
Gng7 | 4108 |
Gng12 | 6533 |
Gnb5 | 7981 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS
1016 | |
---|---|
set | STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS |
setSize | 10 |
pANOVA | 0.0351 |
s.dist | 0.385 |
p.adjustANOVA | 0.153 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Bcl2l1 | 8916 |
Ptpn11 | 8833 |
Cdkn1a | 8310 |
Flt3 | 6517 |
Stat5b | 5705 |
Pim1 | 4435 |
Nox4 | 3163 |
Gab2 | 658 |
Stat5a | -3867 |
Grb2 | -5559 |
GeneID | Gene Rank |
---|---|
Bcl2l1 | 8916 |
Ptpn11 | 8833 |
Cdkn1a | 8310 |
Flt3 | 6517 |
Stat5b | 5705 |
Pim1 | 4435 |
Nox4 | 3163 |
Gab2 | 658 |
Stat5a | -3867 |
Grb2 | -5559 |
FCGR ACTIVATION
321 | |
---|---|
set | FCGR ACTIVATION |
setSize | 11 |
pANOVA | 0.0284 |
s.dist | 0.382 |
p.adjustANOVA | 0.137 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ighg2c | 9022 |
Igkv19-93 | 8911 |
Hck | 7620 |
Fyn | 7293 |
Fgr | 6518 |
Syk | 5230 |
Fcgr3 | 4277 |
Lyn | 1771 |
Src | 1013 |
Yes1 | -2931 |
Fcgr1 | -8194 |
GeneID | Gene Rank |
---|---|
Ighg2c | 9022 |
Igkv19-93 | 8911 |
Hck | 7620 |
Fyn | 7293 |
Fgr | 6518 |
Syk | 5230 |
Fcgr3 | 4277 |
Lyn | 1771 |
Src | 1013 |
Yes1 | -2931 |
Fcgr1 | -8194 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION
883 | |
---|---|
set | RNA POLYMERASE II TRANSCRIPTION TERMINATION |
setSize | 65 |
pANOVA | 1.37e-07 |
s.dist | -0.378 |
p.adjustANOVA | 6.72e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Upf3b | -8113 |
Snrpf | -8050 |
U2af1 | -8027 |
Rbm8a | -7850 |
Alyref | -7740 |
Snrpe | -7726 |
Sarnp | -7240 |
Srsf9 | -7181 |
Snrpd3 | -7029 |
Snrpg | -7014 |
Magohb | -6884 |
Nudt21 | -6797 |
Pcf11 | -6563 |
Srsf4 | -6349 |
Ddx39a | -6217 |
Thoc1 | -6213 |
Ncbp2 | -6200 |
Zc3h11a | -6125 |
Thoc3 | -6071 |
Slu7 | -6024 |
GeneID | Gene Rank |
---|---|
Upf3b | -8113 |
Snrpf | -8050 |
U2af1 | -8027 |
Rbm8a | -7850 |
Alyref | -7740 |
Snrpe | -7726 |
Sarnp | -7240 |
Srsf9 | -7181 |
Snrpd3 | -7029 |
Snrpg | -7014 |
Magohb | -6884 |
Nudt21 | -6797 |
Pcf11 | -6563 |
Srsf4 | -6349 |
Ddx39a | -6217 |
Thoc1 | -6213 |
Ncbp2 | -6200 |
Zc3h11a | -6125 |
Thoc3 | -6071 |
Slu7 | -6024 |
Srsf11 | -5997 |
Srsf2 | -5842 |
U2af2 | -5806 |
Ddx39b | -5634 |
U2af1l4 | -5563 |
Lsm10 | -5519 |
Cpsf4 | -5340 |
Eif4a3 | -5319 |
Magoh | -5137 |
Chtop | -4958 |
Thoc2 | -4940 |
Srsf7 | -4758 |
Srsf6 | -4522 |
Thoc7 | -4438 |
Pabpn1 | -4418 |
Srsf5 | -4141 |
Zfp473 | -4088 |
Cpsf7 | -3129 |
Srrm1 | -2908 |
Srsf1 | -2853 |
Rnps1 | -2675 |
Cstf1 | -2537 |
Srsf3 | -2456 |
Cstf2 | -1888 |
Papola | -1568 |
Dhx38 | -828 |
Poldip3 | -795 |
Cpsf3 | -729 |
Cpsf1 | -326 |
Cstf3 | -322 |
Casc3 | 400 |
Thoc5 | 839 |
Clp1 | 914 |
Sympk | 1357 |
Ncbp1 | 2649 |
Slbp | 2898 |
Wdr33 | 3038 |
Snrpb | 3917 |
Cpsf2 | 4667 |
Thoc6 | 5270 |
Fip1l1 | 6218 |
Lsm11 | 6559 |
Fyttd1 | 6619 |
Cstf2t | 7946 |
Cdc40 | 8378 |
GLUTAMATE AND GLUTAMINE METABOLISM
384 | |
---|---|
set | GLUTAMATE AND GLUTAMINE METABOLISM |
setSize | 13 |
pANOVA | 0.0188 |
s.dist | 0.376 |
p.adjustANOVA | 0.108 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Glul | 8979 |
Glud1 | 8860 |
Rimkla | 6464 |
Got2 | 6181 |
Aldh18a1 | 5490 |
Oat | 5236 |
Kyat1 | 4467 |
Gls2 | 4264 |
Pycr1 | 2739 |
Pycr2 | 1005 |
Gls | 374 |
Rimklb | -1192 |
Pycrl | -5573 |
GeneID | Gene Rank |
---|---|
Glul | 8979 |
Glud1 | 8860 |
Rimkla | 6464 |
Got2 | 6181 |
Aldh18a1 | 5490 |
Oat | 5236 |
Kyat1 | 4467 |
Gls2 | 4264 |
Pycr1 | 2739 |
Pycr2 | 1005 |
Gls | 374 |
Rimklb | -1192 |
Pycrl | -5573 |
RRNA PROCESSING
898 | |
---|---|
set | RRNA PROCESSING |
setSize | 195 |
pANOVA | 1.4e-19 |
s.dist | -0.376 |
p.adjustANOVA | 2.06e-17 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Utp3 | -8205 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Nop58 | -8147 |
Rps27 | -8128 |
Fbl | -8080 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Gar1 | -7972 |
Rps21 | -7927 |
Krr1 | -7912 |
Isg20l2 | -7870 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
GeneID | Gene Rank |
---|---|
Rps28 | -8246 |
Rps29 | -8238 |
Rpl38 | -8230 |
Utp3 | -8205 |
Rpl23 | -8173 |
Rpl39 | -8168 |
Nop58 | -8147 |
Rps27 | -8128 |
Fbl | -8080 |
Rpl37 | -8063 |
Rpl30 | -8019 |
Rpl37a | -7975 |
Gar1 | -7972 |
Rps21 | -7927 |
Krr1 | -7912 |
Isg20l2 | -7870 |
Rpl21 | -7822 |
Rps20 | -7805 |
Rps23 | -7780 |
Rpl36al | -7752 |
Mphosph10 | -7658 |
Rpl35 | -7645 |
Rpl36a | -7632 |
Ncl | -7611 |
Dkc1 | -7545 |
Bms1 | -7542 |
Trmt112 | -7513 |
Rpl23a | -7500 |
Rpl35a | -7461 |
Rps17 | -7426 |
Rps8 | -7421 |
Tex10 | -7349 |
Dcaf13 | -7344 |
Mphosph6 | -7318 |
Rpl31 | -7250 |
Rplp1 | -7160 |
Rpl26 | -7071 |
Rps11 | -7053 |
Rps27a | -7027 |
Rpl24 | -7004 |
Rpp21 | -7003 |
Rpl10a | -6880 |
Rpl36 | -6858 |
Rpl14 | -6787 |
Exosc10 | -6771 |
Rrp1 | -6657 |
Tfb1m | -6643 |
Rps26 | -6585 |
Las1l | -6571 |
Nop14 | -6550 |
Rpl29 | -6490 |
Ddx21 | -6363 |
Rps7 | -6355 |
Rplp2 | -6350 |
Rps19 | -6333 |
Rpl22l1 | -6218 |
Rpl34 | -6199 |
Uba52 | -6187 |
Rpl32 | -6163 |
Rpl18 | -6160 |
Nol12 | -6128 |
Rps12 | -6097 |
Rps25 | -6061 |
Rps15 | -6034 |
Rpl28 | -5977 |
Rps16 | -5972 |
Ftsj3 | -5931 |
Exosc4 | -5921 |
Rpl22 | -5905 |
Fau | -5890 |
Rps6 | -5794 |
Rpl19 | -5752 |
Rpl15 | -5718 |
Rps15a | -5694 |
Exosc7 | -5608 |
Rpl11 | -5571 |
Rps24 | -5471 |
Mterf4 | -5460 |
Ebna1bp2 | -5265 |
Rpl12 | -5252 |
Gnl3 | -5239 |
Rps18 | -5182 |
Rpl13 | -5180 |
Rpl27a | -5162 |
Rpl4 | -5136 |
Exosc3 | -5119 |
Rps5 | -4990 |
Rps9 | -4981 |
Csnk1e | -4914 |
Rpp38 | -4903 |
Rpl8 | -4888 |
Rps4x | -4846 |
Rpl3 | -4835 |
Rpl18a | -4813 |
Utp11 | -4798 |
Rps3a1 | -4631 |
Rpl6 | -4589 |
Rpl7 | -4400 |
Bysl | -4399 |
Nop10 | -4303 |
Rps13 | -4263 |
Rpl27 | -4253 |
Bud23 | -4137 |
Rps27l | -4091 |
Rps2 | -4058 |
Rpl13a | -4006 |
Rpl17 | -3909 |
Nop2 | -3885 |
Fcf1 | -3879 |
Rps14 | -3804 |
Rpp25 | -3503 |
Utp14a | -3360 |
Rpp40 | -3349 |
Pelp1 | -3344 |
C1d | -3335 |
Imp3 | -3334 |
Pdcd11 | -3295 |
Rrp9 | -3259 |
Rpsa | -3236 |
Rpl7a | -2903 |
Rpl9 | -2750 |
Rps10 | -2748 |
Utp18 | -2744 |
Rrp7a | -2728 |
Dis3 | -2517 |
Rbm28 | -2493 |
Nat10 | -2270 |
Imp4 | -2212 |
Nhp2 | -2116 |
Dimt1 | -1988 |
Rps3 | -1626 |
Utp15 | -1549 |
Rpp30 | -1355 |
Rpl3l | -1143 |
Wdr75 | -1100 |
Wdr12 | -1065 |
Nop56 | -998 |
Pwp2 | -769 |
Rrp36 | -680 |
Exosc5 | -520 |
Nob1 | -330 |
Wdr36 | -296 |
Emg1 | -67 |
Riok1 | -18 |
Rpl5 | 46 |
Ltv1 | 108 |
Snu13 | 196 |
Dhx37 | 225 |
Heatr1 | 402 |
Mrm3 | 518 |
Ddx52 | 631 |
Utp20 | 900 |
Tsr3 | 969 |
Rplp0 | 1020 |
Rpl10 | 1911 |
Trmt10c | 2250 |
Pno1 | 2277 |
Exosc9 | 2407 |
Rcl1 | 2409 |
Exosc1 | 2539 |
Wdr46 | 2713 |
Utp25 | 2756 |
Pes1 | 3117 |
Mrm2 | 3276 |
Exosc8 | 3539 |
Utp4 | 3826 |
Rpp14 | 3903 |
Ddx47 | 3985 |
Thumpd1 | 4112 |
Senp3 | 4271 |
Exosc2 | 4603 |
Wdr3 | 4681 |
Utp6 | 4746 |
Wdr43 | 4757 |
Eri1 | 4785 |
Nol6 | 4858 |
Wdr18 | 5003 |
Csnk1d | 5019 |
Ddx49 | 5071 |
Mtrex | 5124 |
Riok3 | 5139 |
Nip7 | 5444 |
Elac2 | 5470 |
Hsd17b10 | 5880 |
Riok2 | 6324 |
Prorp | 6665 |
Nol11 | 6732 |
Tsr1 | 7152 |
Noc4l | 7257 |
Bop1 | 7426 |
Nol9 | 7493 |
Nsun4 | 7675 |
Xrn2 | 7703 |
Tbl3 | 8699 |
Mrm1 | 8798 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE
1049 | |
---|---|
set | SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE |
setSize | 15 |
pANOVA | 0.0136 |
s.dist | 0.368 |
p.adjustANOVA | 0.0892 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fig4 | 8626 |
Sacm1l | 8219 |
Pik3c2a | 8120 |
Pik3c3 | 7990 |
Pi4k2a | 7640 |
Vac14 | 7547 |
Pi4ka | 3300 |
Inpp5e | 2856 |
Arf1 | 1916 |
Pik3r4 | 1359 |
Pikfyve | 957 |
Ocrl | -20 |
Arf3 | -131 |
Pi4k2b | -1848 |
Pi4kb | -3043 |
GeneID | Gene Rank |
---|---|
Fig4 | 8626 |
Sacm1l | 8219 |
Pik3c2a | 8120 |
Pik3c3 | 7990 |
Pi4k2a | 7640 |
Vac14 | 7547 |
Pi4ka | 3300 |
Inpp5e | 2856 |
Arf1 | 1916 |
Pik3r4 | 1359 |
Pikfyve | 957 |
Ocrl | -20 |
Arf3 | -131 |
Pi4k2b | -1848 |
Pi4kb | -3043 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION
442 | |
---|---|
set | INCRETIN SYNTHESIS SECRETION AND INACTIVATION |
setSize | 14 |
pANOVA | 0.0186 |
s.dist | -0.363 |
p.adjustANOVA | 0.108 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Grp | -6868 |
Gng13 | -6025 |
Sec11c | -5958 |
Isl1 | -5637 |
Tcf7l2 | -5581 |
Spcs1 | -5121 |
Gnb3 | -4857 |
Spcs2 | -4537 |
Sec11a | -3700 |
Dpp4 | -3478 |
Pax6 | -794 |
Pcsk1 | -359 |
Ctnnb1 | 6376 |
Spcs3 | 7852 |
GeneID | Gene Rank |
---|---|
Grp | -6868 |
Gng13 | -6025 |
Sec11c | -5958 |
Isl1 | -5637 |
Tcf7l2 | -5581 |
Spcs1 | -5121 |
Gnb3 | -4857 |
Spcs2 | -4537 |
Sec11a | -3700 |
Dpp4 | -3478 |
Pax6 | -794 |
Pcsk1 | -359 |
Ctnnb1 | 6376 |
Spcs3 | 7852 |
CHEMOKINE RECEPTORS BIND CHEMOKINES
146 | |
---|---|
set | CHEMOKINE RECEPTORS BIND CHEMOKINES |
setSize | 18 |
pANOVA | 0.00781 |
s.dist | -0.362 |
p.adjustANOVA | 0.0663 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ccr5 | -7984 |
Cxcl12 | -7200 |
Cxcl1 | -7162 |
Cx3cr1 | -6711 |
Ccl25 | -5824 |
Ccrl2 | -4778 |
Ccl27a | -4404 |
Ccr9 | -3980 |
Ccr10 | -3607 |
Ccl19 | -3284 |
Ackr3 | -3235 |
Cxcr4 | -1892 |
Pf4 | -1725 |
Ackr4 | 54 |
Cx3cl1 | 217 |
Cxcl16 | 3198 |
Ccl28 | 4200 |
Ccr2 | 4577 |
GeneID | Gene Rank |
---|---|
Ccr5 | -7984 |
Cxcl12 | -7200 |
Cxcl1 | -7162 |
Cx3cr1 | -6711 |
Ccl25 | -5824 |
Ccrl2 | -4778 |
Ccl27a | -4404 |
Ccr9 | -3980 |
Ccr10 | -3607 |
Ccl19 | -3284 |
Ackr3 | -3235 |
Cxcr4 | -1892 |
Pf4 | -1725 |
Ackr4 | 54 |
Cx3cl1 | 217 |
Cxcl16 | 3198 |
Ccl28 | 4200 |
Ccr2 | 4577 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES
76 | |
---|---|
set | ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES |
setSize | 10 |
pANOVA | 0.0496 |
s.dist | 0.359 |
p.adjustANOVA | 0.184 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Furin | 7831 |
Mbtps2 | 7435 |
Angptl4 | 6659 |
Pcsk6 | 6642 |
Mbtps1 | 5661 |
Lmf2 | 2394 |
Lmf1 | 1068 |
Lpl | -128 |
Pcsk5 | -521 |
Angptl3 | -2195 |
GeneID | Gene Rank |
---|---|
Furin | 7831 |
Mbtps2 | 7435 |
Angptl4 | 6659 |
Pcsk6 | 6642 |
Mbtps1 | 5661 |
Lmf2 | 2394 |
Lmf1 | 1068 |
Lpl | -128 |
Pcsk5 | -521 |
Angptl3 | -2195 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS
1004 | |
---|---|
set | SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS |
setSize | 11 |
pANOVA | 0.0415 |
s.dist | -0.355 |
p.adjustANOVA | 0.166 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Snrpf | -8050 |
Snrpe | -7726 |
Snrpd3 | -7029 |
Snrpg | -7014 |
Ncbp2 | -6200 |
Lsm10 | -5519 |
Zfp473 | -4088 |
Ncbp1 | 2649 |
Slbp | 2898 |
Snrpb | 3917 |
Lsm11 | 6559 |
GeneID | Gene Rank |
---|---|
Snrpf | -8050 |
Snrpe | -7726 |
Snrpd3 | -7029 |
Snrpg | -7014 |
Ncbp2 | -6200 |
Lsm10 | -5519 |
Zfp473 | -4088 |
Ncbp1 | 2649 |
Slbp | 2898 |
Snrpb | 3917 |
Lsm11 | 6559 |
DISEASES OF DNA REPAIR
241 | |
---|---|
set | DISEASES OF DNA REPAIR |
setSize | 11 |
pANOVA | 0.0431 |
s.dist | -0.352 |
p.adjustANOVA | 0.17 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Nthl1 | -7941 |
Ogg1 | -6237 |
Mlh1 | -5732 |
Mutyh | -5446 |
Bard1 | -5403 |
Neil1 | -4824 |
Pms2 | -1350 |
Msh3 | 342 |
Msh2 | 924 |
Brca1 | 1622 |
Msh6 | 4710 |
GeneID | Gene Rank |
---|---|
Nthl1 | -7941 |
Ogg1 | -6237 |
Mlh1 | -5732 |
Mutyh | -5446 |
Bard1 | -5403 |
Neil1 | -4824 |
Pms2 | -1350 |
Msh3 | 342 |
Msh2 | 924 |
Brca1 | 1622 |
Msh6 | 4710 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.2.1 (2022-06-23)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.1 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] pkgload_1.3.0 GGally_2.1.2
## [3] gtools_3.9.3 echarts4r_0.4.4
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.12.0 limma_3.52.4
## [11] eulerr_6.1.1 mitch_1.8.0
## [13] MASS_7.3-58.1 fgsea_1.22.0
## [15] gplots_3.1.3 DESeq2_1.36.0
## [17] SummarizedExperiment_1.26.1 Biobase_2.56.0
## [19] MatrixGenerics_1.8.1 matrixStats_0.62.0
## [21] GenomicRanges_1.48.0 GenomeInfoDb_1.32.4
## [23] IRanges_2.30.1 S4Vectors_0.34.0
## [25] BiocGenerics_0.42.0 reshape2_1.4.4
## [27] forcats_0.5.2 stringr_1.4.1
## [29] dplyr_1.0.10 purrr_0.3.5
## [31] readr_2.1.3 tidyr_1.2.1
## [33] tibble_3.1.8 ggplot2_3.3.6
## [35] tidyverse_1.3.2 zoo_1.8-11
##
## loaded via a namespace (and not attached):
## [1] googledrive_2.0.0 colorspace_2.0-3 ellipsis_0.3.2
## [4] XVector_0.36.0 fs_1.5.2 rstudioapi_0.14
## [7] bit64_4.0.5 AnnotationDbi_1.58.0 fansi_1.0.3
## [10] lubridate_1.8.0 xml2_1.3.3 codetools_0.2-18
## [13] splines_4.2.1 cachem_1.0.6 knitr_1.40
## [16] geneplotter_1.74.0 jsonlite_1.8.2 broom_1.0.1
## [19] annotate_1.74.0 dbplyr_2.2.1 png_0.1-7
## [22] shiny_1.7.2 compiler_4.2.1 httr_1.4.4
## [25] backports_1.4.1 assertthat_0.2.1 Matrix_1.5-1
## [28] fastmap_1.1.0 gargle_1.2.1 cli_3.4.1
## [31] later_1.3.0 htmltools_0.5.3 tools_4.2.1
## [34] gtable_0.3.1 glue_1.6.2 GenomeInfoDbData_1.2.8
## [37] fastmatch_1.1-3 Rcpp_1.0.9 jquerylib_0.1.4
## [40] cellranger_1.1.0 vctrs_0.4.2 Biostrings_2.64.1
## [43] svglite_2.1.0 xfun_0.33 rvest_1.0.3
## [46] mime_0.12 lifecycle_1.0.3 XML_3.99-0.11
## [49] googlesheets4_1.0.1 zlibbioc_1.42.0 scales_1.2.1
## [52] hms_1.1.2 promises_1.2.0.1 parallel_4.2.1
## [55] RColorBrewer_1.1-3 yaml_2.3.5 memoise_2.0.1
## [58] gridExtra_2.3 sass_0.4.2 reshape_0.8.9
## [61] stringi_1.7.8 RSQLite_2.2.18 highr_0.9
## [64] genefilter_1.78.0 caTools_1.18.2 BiocParallel_1.30.3
## [67] systemfonts_1.0.4 rlang_1.0.6 pkgconfig_2.0.3
## [70] bitops_1.0-7 evaluate_0.17 lattice_0.20-45
## [73] htmlwidgets_1.5.4 bit_4.0.4 tidyselect_1.2.0
## [76] plyr_1.8.7 magrittr_2.0.3 R6_2.5.1
## [79] generics_0.1.3 DelayedArray_0.22.0 DBI_1.1.3
## [82] pillar_1.8.1 haven_2.5.1 withr_2.5.0
## [85] survival_3.4-0 KEGGREST_1.36.3 RCurl_1.98-1.9
## [88] modelr_0.1.9 crayon_1.5.2 KernSmooth_2.23-20
## [91] utf8_1.2.2 rmarkdown_2.17 tzdb_0.3.0
## [94] locfit_1.5-9.6 grid_4.2.1 readxl_1.4.1
## [97] data.table_1.14.2 blob_1.2.3 webshot_0.5.4
## [100] reprex_2.0.2 digest_0.6.29 xtable_1.8-4
## [103] httpuv_1.6.6 munsell_0.5.0 viridisLite_0.4.1
## [106] bslib_0.4.0
END of report